article_Id;author_position;AMSTAR_quality;article;author_code;Author;Institution;City;Pharma company;Country_institution;Documents;Citations;H-index_author;Co-authors
1;1;moderate quality;Psoriasis and sleep disorders: A systematic review;224;Gupta, Aditya K.;University of Toronto, Department of Medicine;Toronto;;Canada;27;84;5;32
1;2;moderate quality;Psoriasis and sleep disorders: A systematic review;225;Gupta, Madhulika A.;Western University, Department of Psychiatry;London;;Canada;117;5008;36;65
1;3;moderate quality;Psoriasis and sleep disorders: A systematic review;557;Simpson, Fiona C.;Mediprobe Research Inc., ;London;yes;Canada;25;292;10;22
2;1;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;621;Van Belkum, Alex;BioMerieux, Marcy-l'Etoile;;;France;529;19862;66;150
2;2;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;55;Bode, Lonneke G M;University Medical Center Utrecht, Department of Medical Microbiology;Utrecht;;Netherlands;11;631;7;51
2;3;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;461;Pasmans, Suzanne G M A;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;101;2405;24;150
2;4;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;612;Totté, Joan E E;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;7;6;2;18
2;5;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;623;Van Der Feltz, W. T.;Utrecht University, Molecular and Cellular Life Sciences;Utrecht;;Netherlands;2;2;1;6
2;6;moderate quality;A systematic review and meta-analysis on Staphylococcus aureus carriage in psoriasis, acne and rosacea;629;Van Zuuren, Esther J.;Leiden University Medical Center - LUMC, Department of Dermatology;Leiden;;Netherlands;90;861;14;129
3;1;moderate quality;The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis;327;Li, Li;The First Hospital of Qinhuangdao, Department of Infection;Qinhuangdao;;China;1;0;NA;3
3;2;moderate quality;The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis;338;Li, Yang;The First Hospital of Qinhuangdao, Department of Scientific Research Management;Qinhuangdao;;China;1;0;NA;3
3;3;moderate quality;The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis;346;Lin, Ningning;The First Hospital of Qinhuangdao, Department of Dermatology;Qinhuangdao;;China;1;0;NA;3
3;4;moderate quality;The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis;695;Yang, Zhengsheng;The First Hospital of Qinhuangdao, Department of Dermatology;Qinhuangdao;;China;1;0;NA;3
4;1;moderate quality;Biomarkers in psoriatic arthritis: a systematic literature review;173;Favalli, Ennio Giulio;Orthopedic Institute Gaetano Pini, Milan, Department of Rheumatology;Milan;;Italy;48;865;16;150
4;2;moderate quality;Biomarkers in psoriatic arthritis: a systematic literature review;201;Generali, Elena;Istituto Clinico Humanitas, Rheumatology and Clinical Immunology;Rozzano;;Italy;14;35;3;44
4;3;moderate quality;Biomarkers in psoriatic arthritis: a systematic literature review;532;Scirè, Carlo Alberto;Italian Society for Rheumatology;Milan;;Italy;68;1134;20;150
4;4;moderate quality;Biomarkers in psoriatic arthritis: a systematic literature review;536;Selmi, Carlo Francesco;Universita degli Studi di Milano, BIOMETRA Department;Milan;;Italy;271;7344;48;150
5;1;low quality;Psoriasis and Associated Psychiatric Disorders A Systematic Review on Etiopathogenesis and Clinical Correlation;126;Da Costa Abreu, José Luís Pio;Universidade de Coimbra, Faculty of Medicine;Coimbra;;Portugal;1;0;NA;3
5;2;low quality;Psoriasis and Associated Psychiatric Disorders A Systematic Review on Etiopathogenesis and Clinical Correlation;127;Da Costa Figueiredo, Américo Manuel;Universidade de Coimbra, Faculty of Medicine;Coimbra;;Portugal;1;0;NA;3
5;3;low quality;Psoriasis and Associated Psychiatric Disorders A Systematic Review on Etiopathogenesis and Clinical Correlation;156;Dos Reis, José Pedro Gaspar;Universidade de Coimbra, Faculty of Medicine;Coimbra;;Portugal;1;0;NA;3
5;4;low quality;Psoriasis and Associated Psychiatric Disorders A Systematic Review on Etiopathogenesis and Clinical Correlation;177;Ferreira, Bárbara Isabel Roque Cunha;Universidade de Lisboa, Centre for Philosophy of Science;Lisbon;;Portugal;1;0;NA;3
6;1;high quality;Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence;184;Frampton, Geoff K;University of Southampton, Faculty of Medicine;Southampton;;United Kingdom;60;1157;21;93
6;2;high quality;Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence;359;Loveman, Emma;Effective Evidence LLP;Eastleigh;;United Kingdom;74;2106;22;92
6;3;high quality;Education to improve quality of life of people with chronic inflammatory skin conditions: a systematic review of the evidence;468;Pickett, Karen;University of Southampton, Southampton Health Technology Assessments Centre;Southampton;;United Kingdom;5;17;2;13
7;1;moderate quality;Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis;45;Bao, Yuting;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;1;0;NA;4
7;2;moderate quality;Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis;223;Guo, Zaipei;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;41;160;7;85
7;3;moderate quality;Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis;645;Wang, Xiaoxue;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;2;0;NA;5
7;4;moderate quality;Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis;687;Yang, Beichen;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;1;0;NA;4
7;5;moderate quality;Epicardial fat tissue in patients with psoriasis:a systematic review and meta-analysis;738;Zhu, Zexin;Sichuan University, Department of Liver Surgery;Chengdu;;China;1;0;NA;4
8;1;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;452;Pan, Haifeng;Anhui Medical University, Department of Biostatistics and Epidemiology;Hefei;;China;220;2012;23;150
8;2;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;639;Wang, Deguang;Anhui Medical University, Department of Nephrology;Hefei;;China;33;272;7;122
8;1;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;640;Wang, Haiyan;Anhui Medical University, Department of Nephrology;Hefei;;China;1;0;NA;6
8;2;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;646;Wang, Xuerong;Anhui Medical University, Department of Nephrology;Hefei;;China;1;0;NA;6
8;1;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;672;Xiao, Jianping;Anhui Medical University, Department of Nephrology;Hefei;;China;1;0;NA;6
8;2;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;699;Ye, Lei;Anhui Medical University, Department of Nephrology;Hefei;;China;8;13;2;44
8;1;moderate quality;Association between rs6887695 and 3′-untranslated region polymorphisms within the interleukin-12B gene and susceptibility to autoimmune diseases in Asian and European population: A meta-analysis;722;Zhang, Sen;Anhui Medical University, Department of Nephrology;Hefei;;China;2;0;NA;13
9;1;moderate quality;Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review;16;Andersen, Flemming J.;Syddansk Universitet;Odense;;Denmark;25;126;7;36
9;2;moderate quality;Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review;17;Andersen, Klaus Ejner Jner;Odense Universitetshospital, Department of Dermatology and Allergy Centre;Odense;;Denmark;8;51;2;55
9;3;moderate quality;Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review;232;Hansen, Jakob;LEO Pharma AS;Ballerup;yes;Denmark;1;0;NA;4
9;4;moderate quality;Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review;272;Johannessen, Helle;Syddansk Universitet, Department of Public Health;Odense;;Denmark;23;206;9;49
9;5;moderate quality;Medical adherence to topical corticosteroid preparations prescribed for psoriasis: A systematic review;586;Svendsen, Mathias Tiedemann Iedemann;Odense Universitetshospital, Department of Dermatology and Allergy Centre;Odense;;Denmark;10;2;1;20
10;1;moderate quality;Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials;183;Foerster, John P.;University of Dundee, Department of Dermatology and Photobiology;Dundee;;United Kingdom;29;828;16;132
10;2;moderate quality;Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials;442;Ogston, Simon Alexander;University of Dundee, School of Medicine;Dundee;;United Kingdom;164;5014;38;150
10;3;moderate quality;Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials;654;West, Jonathan;University of Dundee, School of Medicine;Dundee;;United Kingdom;2;1;1;7
12;1;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;49;Bessette, Louis;Universite Laval, Department of Medicine;Quebec;;Canada;73;1703;23;150
12;2;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;55;Bissonnette, Robert T.;Innovaderm Research Inc.;Montreal;yes;Canada;127;2846;29;150
12;3;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;162;Dutz, Jan Peter;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;114;3307;31;150
12;4;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;182;Fleming, Patrick James;University of Toronto, Division of Dermatology;Toronto;;Canada;20;180;6;37
12;5;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;219;Gulliver, Wayne P F;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;86;2562;25;150
12;6;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;234;Haraoui, Boulos Paul;Universite de Montreal;Montreal;;Canada;150;5023;36;150
12;7;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;281;Keeling, Stephanie O.;Memorial University of Newfoundland, Faculty of Medicine;St John's;;Canada;19;194;8;111
12;8;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;294;Kraft, John N.;Lynde Centre for Dermatology;Markham;;Canada;19;298;8;30
12;9;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;366;Lynde, Charles W.;University of Toronto, Division of Dermatology;Toronto;;Canada;144;3588;31;150
12;10;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;399;McCourt, Collette;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;7;74;3;19
12;11;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;401;McFarlane, Alexandra;University of Alberta, Division of Rheumatology;Edmonton;;Canada;8;76;3;20
12;12;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;477;Pope, Janet Elizabeth;Western University, Department of Medicine;London;;Canada;198;5525;38;150
12;13;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;501;Richer, Vincent;St-Luc Hospital, Department of Medicine;Quebec;;Canada;14;81;4;32
12;14;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;510;Roubille, Camille;Universite de Montreal;Montreal;;Canada;35;310;9;106
12;15;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;574;Starnino, Tara;Universite de Montreal, Sacré-Coeur Hospital;Montreal;;Canada;7;74;3;19
12;16;moderate quality;Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity;558;Siu, Stephanie;University of the West, Division of Rheumatology;London;;United Kingdom;6;71;3;17
15;1;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;11;Almeida, Isabel F.;Universidade do Porto, Departamento de Ciências do Medicamento;Porto;;Portugal;31;383;13;70
15;2;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;12;Almeida, Vera;Cooperativa de Ensino Superior, Politecnico e Universitaria;;;Portugal;1;0;NA;5
15;3;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;569;Sousa Lobo, José Manuel;Universidade do Porto, Department of Drug Sciences;Porto;;Portugal;47;2347;11;77
15;4;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;594;Teixeira, Ana;Universidade do Porto, Departamento de Ciências do Medicamento;Porto;;Portugal;1;0;NA;5
15;5;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;596;Teixeira, Maribel;Cooperativa de Ensino Superior, Politecnico e Universitaria;;;Portugal;1;0;NA;5
15;6;low quality;Methodologies for medication adherence evaluation: Focus on psoriasis topical treatment;611;Torres, Tiago S.;Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar;Porto;;Portugal;79;220;6;92
16;1;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;15;Ananthakrishnan, Ashwin N;Massachusetts General Hospital, Gastroenterology Unit;Boston;;United States;189;4988;33;150
16;2;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;111;Colombel, Jean Frédéric;Icahn School of Medicine at Mount Sinai, Division of Gastroenterology;New York;;United States;757;52681;108;150
16;3;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;302;Laharie, David;Universite de Bordeaux, Department of Gastroenterology;Bordeaux;;United States;84;2734;27;150
16;4;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;319;Lewis, James D.;Fordham University;New York;;United States;237;11859;56;150
16;5;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;379;Mamtani, Ronac;University of Pennsylvania;Philadelphia;;United States;43;777;8;130
16;6;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;533;Scott, Frank I.;University of Pennsylvania;Philadelphia;;United States;27;76;5;62
16;7;high quality;Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis;544;Shelton, Edward;Massachusetts General Hospital, Gastroenterology Unit;Boston;;United States;4;21;2;30
17;1;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;90;Chang, Suyueh;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;3;5;1;14
17;2;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;394;May, Brian H;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;49;249;10;74
17;3;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2568;24;150
17;4;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947 ;16;150
17;5;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;712;Zhang, Claireshuiqing;Royal Melbourne Institute of Technology University, School of Biomedical Science;Melbourne;;Australia;19;73;6;30
17;6;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;221;Guo, Xinfeng;Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;44;134 ;6;110
17;7;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
17;8;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;685;Yan, Yuhong;Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Dermatology;Guangzhou;;China;6;6;1;21
17;9;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;697;Yao, Danni;Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Dermatology;Guangzhou;;China;5;6;1;19
17;10;low quality;Terms referring to psoriasis vulgaris in the classical Chinese medicine literature: a systematic analysis;705;Yu, Jasonjingjie;Guangdong Provincial Hospital of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;5;13;2;11
18;1;moderate quality;Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review;93;Chen, Hongduo;China Medical University Shenyang, Department of Dermatology;Shenyang;;China;7;0;NA;23
18;2;moderate quality;Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review;193;Gao, Xinghua;China Medical University Shenyang, Department of Dermatology;Shenyang;;China;6;0;NA;21
18;3;moderate quality;Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review;268;Jiang, Shibin;China Medical University Shenyang, Department of Dermatology;Shenyang;;China;1;0;NA;4
18;4;moderate quality;Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review;669;Wu., Yan;Shanghai Jiaotong University, School of Nuclear Science and Engineering;Shanghai;;China;1314;16535;57;150
18;5;moderate quality;Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review;683;Yan, Ru;China Medical University Shenyang, Department of Dermatology;Shenyang;;China;1;0;NA;4
19;1;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;49;249;10;74
19;2;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2567;24;150
19;3;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947;16;150
19;4;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;712;Zhang, Claireshuiqing;Royal Melbourne Institute of Technology University, School of Biomedical Sciences;Melbourne;;Australia;19;73;6;30
19;5;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;221;Guo, Xinfeng;Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;44;134;6;110
19;6;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
19;7;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;691;Yang, Lihong;Guangzhou University, Second Clinical Medical College;Guangzhou;;China;6;72;3;31
19;8;high quality;Is Oral Chinese Herbal Medicine Beneficial for Psoriasis Vulgaris? A Meta-Analysis of Comparisons with Acitretin.;705;Yu, Jasonjingjie;Guangdong Provincial Hospital of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;5;13;2;11
20;1;moderate quality;Risk of Parkinson's Disease Among Patients with Psoriasis: Review and Meta-analysis;618;Ungprasert, Patompong;Mahidol University, Department of Medicine;Nakon Pathom;;Thailand;126;318;11;114
20;2;moderate quality;Risk of Parkinson's Disease Among Patients with Psoriasis: Review and Meta-analysis;291;Kittanamongkolchai, Wonngarm;Mayo Clinic, Department of Internal Medicine;Rochester;;United States;40;144;6;41
20;3;moderate quality;Risk of Parkinson's Disease Among Patients with Psoriasis: Review and Meta-analysis;573;Srivali, Narat;Mayo Clinic, Div. of Pulmon./Critical Care Med.,;Rochester;;United States;103;168;6;61
21;1;high quality;Topical treatments for scalp psoriasis;65;Brown, Benjamin C.;University of Manchester, Health Services - Primary Care;Manchester;;United Kingdom;15;254;7;25
21;2;high quality;Topical treatments for scalp psoriasis;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25834;85;150
21;3;high quality;Topical treatments for scalp psoriasis;650;Warren, R. B;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;98;1906;22;150
22;1;moderate quality;A systematic review on the efficacy and safety of Infliximab in patients with psoriasis;642;Wang, Jin;Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital;Tianjin;;China;1;0;NA;2
22;2;moderate quality;A systematic review on the efficacy and safety of Infliximab in patients with psoriasis;708;Zhan, Qingxia;Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital;Tianjin;;China;1;0;NA;2
22;3;moderate quality;A systematic review on the efficacy and safety of Infliximab in patients with psoriasis;719;Zhang, Litao;Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital;Tianjin;;China;1;0;NA;2
23;1;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;79;Cañeté, Juan De Dios;Hospital Clinic Barcelona;Barcelona;;Spain;138;2999;28;150
23;2;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;109;Cobo-Ibáñez, Tatiana;Universidad Autonoma de Madrid;Madrid;;Spain;21;354;10;65
23;3;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;139;Del Campo, Petra Díaz;Spanish Society of Rheumatology, Research Unit;Madrid;;Spain;2;4;1;19
23;4;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;218;Guerra-Rodríguez, Mercedes;Spanish Society of Rheumatology, Research Unit;Madrid;;Spain;6;164;3;21
23;5;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;421;Muñoz-Fernández, Santiago;Hospital Universitario Infanta Sofía;Madrid;;Spain;77;817;18;150
23;6;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;537;Seoane-Mato, Daniel;Spanish Society of Rheumatology, Research Unit;Madrid;;Spain;7;3;1;48
23;7;moderate quality;Multidisciplinary dermatology–rheumatology management for patients with moderate‑to‑severe psoriasis and psoriatic arthritis: a systematic review;635;Villaverde, Virginia;Hospital de Mostoles, Rheumatology Unit;Madrid;;Spain;24;542;11;150
24;1;moderate quality;Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis;550;Shi, Deshun;Southern Medical University, Department of Dermatology;TongHe;;China;2;0;NA;3
24;2;moderate quality;Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis;665;Wu, Dongze;Southern Medical University, Department of Dermatology;TongHe;;China;2;0;NA;3
24;3;moderate quality;Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis;690;Yang, Li;Qingdao University, School of Medicine, Department of Epidemiology and Health Statistics;Qingdao;;China;5;0;NA;21
24;4;moderate quality;Association between methylenetetrahydrofolate reductase C677T polymorphism and psoriasis: A meta-analysis;737;Zhu, Xiaoliang;Southern Medical University, Department of Dermatology;TongHe;;China;14;28;3;32
26;1;moderate quality;Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis;94;Chen, Hongquan;Qingdao University, Department of Dermatology;Qingdao;;China;2;0;NA;6
26;2;moderate quality;Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis;335;Li, Xia;Qingdao University, Department of Dermatology;Qingdao;;China;1;0;NA;2
26;3;moderate quality;Effects of Narrow Band Ultraviolet B on Serum Levels of Vascular Endothelial Growth Factor and Interleukin-8 in Patients with Psoriasis;590;Tang, Rong;Qingdao University, Department of Dermatology;Qingdao;;China;1;0;NA;2
27;1;low quality;Targeted phototherapy;425;Mysore, Venkataram;Centre for Advanced Dermatology and Post Graduate Training;Bengaluru;;India;25;103 ;7;36
27;2;low quality;Targeted phototherapy;542;Shashikumar, B. M.;Venkat Charmalaya, Department of Dermatology;Bengaluru;;India;14;29;3;15
28;1;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;321;Li, Bin;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;8;3;1;37
28;2;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;322;Li, Fulun;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;4;1;1;21
28;3;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;336;Li, Xin;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;14;33;4;52
28;4;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;408;Miao, Xiao;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;2;1;1;9
28;5;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;647;Wang, Yifei;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;14;32;4;42
28;6;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;123;Cui, Rutao;Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics;Boston;;United States;29;894;12;150
28;7;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;641;Wang, Hongshen;Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics;Boston;;United States;3;1;1;16
28;8;moderate quality;Association of Serum Uric Acid Levels in Psoriasis A Systematic Review and Meta-Analysis;693;Yang, Qiong;Boston University School of Public Health, Department of Statistics;Boston;;United States;1;0;NA;7
29;1;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;169;Fan, Bin;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;2;0;NA;10
29;2;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;321;Li, Bin;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;8;3;1;37
29;3;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;322;Li, Fulun;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;22;213;7;100
29;4;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;333;Li, Su;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;2;1;1;14
29;5;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;336;Li, Xin;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;14;33;4;52
29;6;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;465;Peng, Shiguang;Capital Medical University China, Department of Dermatology;Beijing;;China;2;0;NA;18
29;7;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;668;Wu, Minfeng;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;1;0;NA;10
29;8;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;673;Xiao, Qingqing;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;2;1;1;14
29;9;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;676;Xu, Rong;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;13;42;5;47
29;10;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;734;Zhou, Min;Shanghai Academy of Traditional Chinese Medicine, Institute of Dermatology;Shanghai;;China;13;17;2;40
29;11;high quality;Immune Signatures in Patients with Psoriasis Vulgaris of Blood-Heat Syndrome: A SystematicReview and Meta-Analysis;95;Chen, Jie;Dana-Farber Cancer Institute, Bing Center for Waldenstr Öm's Macroglobulinemia;Boston;;United States;12;55;3;71
30;1;moderate quality;Psoriasis treatment and management – a systematic review of full economic evaluations;132;Davies, Linda Mary;University of Manchester, Department of Psychology;Manchester;;United Kingdom;105;4570;35;150
30;2;moderate quality;Psoriasis treatment and management – a systematic review of full economic evaluations;216;Griffiths, Christopher E. M.;University of Manchester, Centre for Dermatology Research;Manchester;;United Kingdom;17;42;4;61
30;3;moderate quality;Psoriasis treatment and management – a systematic review of full economic evaluations;228;Hamilton, Matthew P.;University of Manchester, Institute of Population Health;Manchester;;United Kingdom;3;3;1;12
30;4;moderate quality;Psoriasis treatment and management – a systematic review of full economic evaluations;438;Ntais, Dionysios;University of Manchester, Institute of Population Health;Manchester;;United Kingdom;3;3;1;12
31;1;low quality;Patient-reported outcome measures in psoriasis: the good, the bad and the missing!;70;Bundy, Christine E.;University of Manchester, Greater Manchester Collaboration for Leadership in Applied Health Research and Care;Manchester;;United Kingdom;76;1265;18;150
31;2;low quality;Patient-reported outcome measures in psoriasis: the good, the bad and the missing!;113;Cordingley, Lis;University of Manchester, Manchester Centre for Health Psychology;Manchester;;United Kingdom;48;710;13;121
31;3;low quality;Patient-reported outcome measures in psoriasis: the good, the bad and the missing!;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25840;85;150
31;4;low quality;Patient-reported outcome measures in psoriasis: the good, the bad and the missing!;290;Kitchen, Helen;University of Manchester, Centre for Dermatology Research;Manchester;;United Kingdom;6;34;3;21
31;5;low quality;Patient-reported outcome measures in psoriasis: the good, the bad and the missing!;704;Young, Helen S.;University of Manchester, Centre for Dermatology Research;Manchester;;United Kingdom;2;10;1;9
32;1;low quality;Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis;264;Ji, Eunhee;Gachon University, Seongnam-si;Gyeonggi-do;;South Korea;1;2;1;3
32;2;low quality;Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis;516;Ryoo, Juyeon;Gachon University, Seongnam-si;Gyeonggi-do;;South Korea;2;6;2;3
32;3;low quality;Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis;688;Yang, Hyejin;Gachon University, Seongnam-si;Gyeonggi-do;;South Korea;2;6;2;3
32;4;low quality;Meta-analysis of the Efficacy and Safety of Secukinumab for the Treatment of Plaque Psoriasis;702;Yoo, Bongkyu;Gachon University, College of Pharmacy, Seongnam-si;Gyeonggi-do;;South Korea;52;1084;16;117
33;1;moderate quality;The epidemiology of childhood psoriasis: a scoping review;422;Murphy, Ruth Ann;National University of Ireland Galway, Department of Psychiatry;Galway;;Ireland;60;666;12;150
33;2;moderate quality;The epidemiology of childhood psoriasis: a scoping review;4;Adaji, E.;University of Nottingham, Division of Epidemiology and Public Health;Nottingham;;United Kingdom;2;1;1;5
33;3;moderate quality;The epidemiology of childhood psoriasis: a scoping review;71;Burden-Teh, Esther;University of Nottingham, School of Medicine;Nottingham;;United Kingdom;14;56;3;69
33;4;moderate quality;The epidemiology of childhood psoriasis: a scoping review;217;Grindlay, Douglas Jc C;University of Nottingham, School of Medicine;Nottingham;;United Kingdom;30;752;13;35
33;5;moderate quality;The epidemiology of childhood psoriasis: a scoping review;496;Ratib, Sonia;University of Nottingham, School of Medicine;Nottingham;;United Kingdom;21;593;12;78
33;6;moderate quality;The epidemiology of childhood psoriasis: a scoping review;604;Thomas, Kim S.;University of Nottingham, Centre of Evidence Based Dermatology,;Nottingham;;United Kingdom;71;1200;19;150
34;1;low quality;Systematic review of efficacy of antietumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different antieTNF agent;55;Bissonnette, Robert T.;Innovaderm Research Inc.;Montreal;yes;Canada;127;2846;29;150
34;2;low quality;Systematic review of efficacy of antietumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different antieTNF agent;595;Teixeira, Henrique D.;AbbVie, North Chicago;Chicago;yes;United States;11;37;3;34
34;3;low quality;Systematic review of efficacy of antietumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different antieTNF agent;620;Valdecantos, Wendell C.;AbbVie, North Chicago;Chicago;yes;United States;7;50;2;22
34;4;low quality;Systematic review of efficacy of antietumor necrosis factor (TNF) therapy in patients with psoriasis previously treated with a different antieTNF agent;681;Yamauchi, Paul;David Geffen School of Medicine at UCLA, Division of Dermatology;Los Angeles;;United States;51;1534;21;95
35;1;moderate quality;Association Between Psoriasis and Subclinical Atherosclerosis A Meta-Analysis;171;Fan, Yu;Jiangsu University, Institute of Molecular Biology and Translational Medicine;Zhenjiang;;China;129;710;15;150
35;2;moderate quality;Association Between Psoriasis and Subclinical Atherosclerosis A Meta-Analysis;172;Fang, Na;Jiangsu University, Institute of Molecular Biology and Translational Medicine;Zhenjiang;;China;4;7;2;7
35;3;moderate quality;Association Between Psoriasis and Subclinical Atherosclerosis A Meta-Analysis;267;Jiang, Menglin;Jiangsu University, Institute of Molecular Biology and Translational Medicine;Zhenjiang;;China;4;3;1;6
36;1;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;293;Kong, Lingjun;Shanghai Academy of Traditional Chinese Medicine, Research Institute of Tuina;Shanghai;;China;1;0;NA;8
36;2;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;321;Li, Bin;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;6;5;1;35
36;3;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;322;Li, Fulun;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;2;0;NA;14
36;4;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;465;Peng, Shiguang;Capital Medical University China, Department of Dermatology;Beijing;;China;2;0;NA;18
36;5;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;676;Xu, Rong;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;5;21;1;35
36;6;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;734;Zhou, Min;Shanghai University of Traditional Chinese Medicine, Department of Dermatology;Shanghai;;China;2;0;NA;14
36;7;moderate quality;Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis;618;Ungprasert, Patompong;Mahidol University, Department of Medicine;Nakon Pathom;;Thailand;126;318;11;114
36;8;moderate quality;Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis;573;Srivali, Narat;Mayo Clinic, Div. of Pulmon./Critical Care Med.,;Rochester;;United States;103;168;6;61
36;9;moderate quality;Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis;606;Thongprayoon, Charat;Mayo Clinic, Division of Nephrology and Hypertension;Rochester;;United States;96;192;7;133
36;10;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;92;Chen, Chen;Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics;Boston;;United States;3;6;1;27
36;11;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;336;Li, Xin;Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics;Boston;;United States;1;0;NA;8
36;12;high quality;Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis;641;Wang, Hongshen;Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics;Boston;;United States;3;1;1;16
37;1;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;563;Smolen, Josef Sebastian;Medizinische Universitat Wien, Department of Medicine;Vienna;;Austria;819;52519;103;150
37;2;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;358;Lortholary, O.;Universite Paris Descartes;Paris;;France;2;11;1;17
37;3;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;383;Mariette, Xavier;Centre de Recherche en Immunologie des Infections virales et des maladies auto-immunes;Le Kremlin-Bicetre;;France;426;15280;67;150
37;4;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;48;Bartalesi, Filippo;Azienda Ospedaliera Careggi, Infectious Diseases Unit;Florence;;Italy;66;1245;20;150
37;5;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;348;Lipman, Marc CI I;National Health Service;London;;United Kingdom;198;4287;36;150
37;6;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;35;Baddley, John W.;University of Alabama at Birmingham;Birmingham;;United States;129;4074;31;150
37;7;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;75;Calabrese, Leonard H.;Cleveland Clinic Foundation;Cleveland;;United States;280;16098;60;150
37;8;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;104;Chiller, Tom M.;National Center for Emerging and Zoonotic Infectious Diseases, and Environmental Diseases;Atlanta;;United States;126;5282 ;32;150
37;9;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;437;Novosad, Shannon A.;National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion;Atlanta;;United States;10;34;3;67
37;10;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;475;Polgreen, Philip M.;University of Iowa Caver College of Medicine, College of Public Health;Iowa City;;United States;140;2352;23;150
37;11;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;519;Saag, Michael S.;University of Alabama at Birmingham, Division of Infectious Diseases;Birmingham;;United States;4;100;2;150
37;12;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;651;Weinblatt, Michael E.;Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy;Boston;;United States;291;27048 ;67;150
37;13;low quality;Opportunistic infections and biologic therapies in immune-mediated inflammatory diseases: consensus recommendations for infection reporting during clinical trials and postmarketing surveillance;659;Winthrop, Kevin L.;University of Alabama at Birmingham, Department of Medicine;Birmingham;;United States;174;8847;41;150
38;1;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;48;Bérenbaum, Françis;Universite Paris Sorbonne - Paris IV;Paris;;France;249;5428;41;150
38;2;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;144;Depont, Fanny;SC Partners;Paris;yes;France;18;443;10;65
38;3;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;179;Filippi, Jérôme Ôme;Hopital l'Archet, Hepato-gastroenterology Unit;Nice;;France;47;1246;17;150
38;4;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
38;5;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;431;Nataf, Henri;Cabinet de Rheumatologie;Mantes-la-Jolie;;France;14;72;5;67
38;6;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275;39;150
38;7;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;467;Peyrin-Biroulet, Laurent;Universite de Lorrain, Department of Gastroenterology;Nancy;;France;2;0;NA;16
38;8;moderate quality;Interventions to Improve Adherence in Patients with Immune-Mediated Inflammatory Disorders: A Systematic Review;603;Thibout, Emmanuel;AbbVie, North Chicago;Chicago;yes;United States;6;28;2;45
39;1;moderate quality;EQ-5D in skin conditions: an assessment of validity and responsiveness;60;Brazier, John L.;University of Sheffield, School of Health and Related Research;Sheffield;;United Kingdom;7;18;3;27
39;2;moderate quality;EQ-5D in skin conditions: an assessment of validity and responsiveness;356;Longworth, Louise J.;Brunel University London, Health Economics Research Group;Uxbridge;;United Kingdom;56;946;17;150
39;3;moderate quality;EQ-5D in skin conditions: an assessment of validity and responsiveness;694;Yang, Yaling;University of Oxford, Nuffield Department of Primary Care Health Sciences;Oxford;;United Kingdom;5;6;2;18
41;1;low quality;Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis;312;Lee, Youngho;Sungkyunkwan University, Department of Physics;Jongno-gu;;South Korea;278;4597;35;150
41;2;low quality;Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis;568;Song, Gwangyu;Korea University Medical Center, Department of Internal Medicine;Seoul;;South Korea;245;3451;29;150
42;1;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;418;Mrowietz, Ulrich;Universitatsklinikum Schleswig-Holstein Campus Kiel, Psoriasis-Center at the Department of Dermatology;Kiel;;Germany;258;7879;50;150
42;2;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;40;Baker, Anna;Atlantis Healthcare;London;;United Kingdom;2;0;NA;15
42;3;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;41;Bakhshi, Savita;King's College London, Florence Nightingale School of Nursing and Midwifery;London;;United Kingdom;10;22;3;19
42;4;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;68;Bucknor, Delaney;London Metropolitan University;London;;United Kingdom;2;9;1;11
42;5;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;180;Fisher, Abigail;UCL;London;;United Kingdom;1;0;NA;9
42;6;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;447;Östör, Andrew Jk K;University of Cambridge, Rheumatology Research Unit;Cambridge;;United Kingdom;84;1532;22;150
42;7;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;467;Peyrin-Biroulet, Laurent;Universite de Lorrain, Department of Gastroenterology;Nancy;;United Kingdom;2;0;NA;16
42;8;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;630;Vangeli, Eleni;London South Bank University, Department of Psychology;London;;United Kingdom;13;304;9;40
42;9;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;652;Weinman, John A.;King's College London, Institute of Pharmaceutical Science;London;;United Kingdom;234;14525;57;150
42;10;moderate quality;A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases;301;Lacerda, Ana P.;AbbVie, North Chicago;Chicago;yes;United States;1;0;NA;9
44;1;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;49;249;10;74
44;2;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2568;24;150
44;3;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947;16;150
44;4;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;712;Zhang, Claireshuiqing;Royal Melbourne Institute of Technology University, School of Biomedical Sciences;Melbourne;;Australia;19;73;6;30
44;5;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;221;Guo, Xinfeng;Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;44;134;6;110
44;6;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
44;7;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;691;Yang, Lihong;Guangzhou University, Second Clinical Medical College;Guangzhou;;China;6;72;3;31
44;8;moderate quality;Efficacy of combining oral Chinese herbal medicine and NB‑UVB in treating psoriasis vulgaris: a systematic review and meta‑analysis;706;Yu, Jingjie;Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Dermatology;Guangzhou;;China;5;8;2;18
45;1;moderate quality;The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review;182;Fleming, Patrick James;University of Toronto, Division of Dermatology;Toronto;;Canada;20;180;6;37
45;2;moderate quality;The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review;219;Gulliver, Wayne P F;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;86;2562;25;150
45;3;moderate quality;The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review;294;Kraft, John N.;Lynde Centre for Dermatology;Markham;;Canada;19;298;8;30
45;4;moderate quality;The Relationship of Obesity With the Severity of Psoriasis: A Systematic Review;366;Lynde, Charles W.;University of Toronto, Division of Dermatology;Toronto;;Canada;144;3588;31;150
47;1;moderate quality;Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis;526;Sanguankeo, Anawin;Mahidol University, Department of Social and Preventive Medicine;Nakon Pathom;;Thailand;51;61;5;49
47;2;moderate quality;Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis;619;Upala, Sikarin;Mahidol University, Department of Social and Preventive Medicine;Nakon Pathom;;Thailand;49;49;4;48
48;1;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;48;Bauer, Andrea;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;7;21;3;33
48;2;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;471;Piguet, Vincent;Cardiff University, Institute of Infection and Immunity;Cardiff;;United Kingdom;132;4859;31;150
48;3;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;2;Abbott, Rachel Angharad;University Hospital of Wales, Welsh Institute of Dermatology;Cardiff;;United Kingdom;20;153;6;61
48;4;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;28;Atwan, Ausama A.;Cardiff University, Department of Dermatology;Cardiff;;United Kingdom;6;41;3;16
48;5;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;255;Ingram, John R.;Cardiff University, Department of Dermatology and Wound Healing;Cardiff;;United Kingdom;4;8;1;37
48;6;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;283;Kelson, Mark J.;Cardiff University, South East Wales Trials Unit;Cardiff;;United Kingdom;6;1;1;32
48;7;high quality;Oral fumaric acid esters for psoriasis: Abridged Cochrane systematic review including GRADE assessments;469;Pickles, Timothy;Cardiff University, School of Medicine;Cardiff;;United Kingdom;20;158;6;121
49;1;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;151;Ding, Hongwei;First People's Hospital of Yueyang, Dermatological Department;Yueyang;;China;1;0;NA;6
49;2;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;222;Guo, Xiuli;First People's Hospital of Yueyang, Dermatological Department;Yueyang;;China;1;0;NA;6
49;3;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;252;Huang, Huiyun;First People's Hospital of Yueyang, Dermatological Department;Yueyang;;China;1;0;NA;6
49;4;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;546;Shen, Erdong;First People's Hospital of Yueyang, Department of Oncology ;Yueyang;;China;2;0;NA;10
49;5;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;589;Tan, Xingyou;First People's Hospital of Yueyang, Dermatological Department;Yueyang;;China;1;0;NA;6
49;6;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;591;Tang, Shiqing;First People's Hospital of Yueyang, Dermatological Department;Yueyang;;China;1;0;NA;6
49;7;moderate quality;Increased serum resistin levels correlate with psoriasis: a meta-analysis;644;Wang, Qiang;Nanchang University, Department of Orthopaedics;Nanchang;;China;3;0;NA;12
50;1;low quality;Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability;202;Gilbert, Kathleen E.;Indiana University-Purdue University Indianapolis, School of Medicine;Indianapolis;;United States;7;5;2;2
50;2;low quality;Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability;380;Manalo, Iviensan F.;Medical College of Georgia;Augusta;;United States;9;5;2;8
50;3;low quality;Subcutaneous methotrexate for symptomatic control of severe recalcitrant psoriasis: safety, efficacy, and patient acceptability;667;Wu, Jashin J.;Kaiser Permanente, Department of Dermatology;San Francisco;;United States;151;1204;17;143
51;1;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;76;Calapai, Fabrizio;Universita degli Studi di Messina, Department of Clinical and Experimental Medicine;Messina;;Italy;8;33;3;22
51;2;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;77;Calapai, Gioacchino;Universita degli Studi di Messina;Messina;;Italy;131;3460;32;150
51;3;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;191;Gangemi, Sebastiano;Universita degli Studi di Messina;Messina;;Italy;226;1831;20;150
51;4;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;203;Giofrè, Salvatore Vincenzo;Universita degli Studi di Messina, Department of Chemical Sciences;Messina;;Italy;39;287;10;128
51;5;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;381;Mancari, Ferdinando;Universita degli Studi di Messina, Department of Drug Sciences and Health Products;Messina;;Italy;8;105;5;34
51;6;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;432;Navarra, Michele;Universita degli Studi di Messina, Department of Pharmacology;Messina;;Italy;85;965;18;150
51;7;moderate quality;Review of Clinical Pharmacology of Aloe vera L. in the Treatment of Psoriasis;412;Miroddi, Marco;University of York, Centre for Reviews and Dissemination;York;;United Kingdom;21;69;5;37
53;1;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;52;Bhandari, Sahil;University of Manchester School of Medicine;Manchester;;United Kingdom;1;0;NA;5
53;2;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;70;Bundy, Christine E.;University of Manchester, Greater Manchester Collaboration for Leadership in Applied Health Research and Care;Manchester;;United Kingdom;76;1265;18;150
53;3;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;106;Chisholm, Anna;University of Manchester, Manchester Centre for Dermatology and Manchester Centre for Health Psychology;Manchester;;United Kingdom;19;104;6;39
53;4;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25840;85;150
53;5;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;242;Henry, Alasdair L.;University of Manchester, Institute of Inflammation and Repair;Manchester;;United Kingdom;3;4;1;10
53;6;moderate quality;Measurement, Classification and Evaluation of Sleep Disturbance in Psoriasis: A Systematic Review;299;Kyle, Simon David;University of Manchester, School of Psychological Sciences;Manchester;;United Kingdom;41;520;10;112
54;1;high quality;Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis;26;Arrese, Marco A.;Pontificia Universidad Catolica de Chile, Department of Gastroenterology;Santiago de Chile;;Chile;139;2976;30;150
54;2;high quality;Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis;78;Cândia, Roberto;Pontificia Universidad Catolica de Chile, Department of Gastroenterology;Santiago de Chile;;Chile;12;78;5;80
54;3;high quality;Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis;514;Ruiz, Alex;Universidad Austral de Chile, Faculty of Medicine ;Valdivia;;Chile;5;59;3;37
54;4;high quality;Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis;610;Torres-Robles, R.;Pontificia Universidad Catolica de Chile, Sistema de Bibliotecas UC;Santiago de Chile;;Chile;2;6;1;13
54;5;high quality;Risk of non-alcoholic fatty liver disease in patients with psoriasis: A systematic review and meta-analysis;91;Chávez-Tapia, Norberto Carlos Arlos;Fundacion Clinica Medica Sur, Translational Research Unit;Mexico City;;Mexico;138;1463;21;150
55;1;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;130;Dannepond, Carole;Centre Hospitalier Regional et Universitaire de Tours, Department of Dermatology;Besancon;;France;7;4;1;22
55;2;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;372;Machet, Laurent;Inserm;Paris;;France;245;3436;31;150
55;3;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;388;Maruani, Annabe;Hopital Trousseau, Department of Dermatology;Tours;;France;4;2;1;42
55;4;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;450;Paintaud, Gille;Universite Francois-Rabelais Tours, Laboratory of Pharmacology-Toxicology;Tours;;France;2;1;1;7
55;5;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;522;Samimi, Mahta;Centre Hospitalier Regional et Universitaire de Tours, Department of Dermatology;Tours;;France;2;1;1;8
55;6;moderate quality;Serum Infliximab Concentrations in Psoriatic Patients Treated with Infliximab: A Systematic Review;599;Ternant, David;Laboratoire de Pharmacologie-Toxicologie;Tours;;France;50;1175;17;150
56;1;low quality;Sexual dysfunction in psoriasis: a systematic review;270;Jimenez-Moleon, Jose J.;CIBER de Epidemiología y Salud Pública;Madrid;;Spain;91;736;16;150
56;2;low quality;Sexual dysfunction in psoriasis: a systematic review;415;Molina-Leyva, Alejandro Alejandro;Complejo Hospitalario Torrecardenas de Almeria, Department of Dermatology;Almeria;;Spain;16;13;2;23
56;3;low quality;Sexual dysfunction in psoriasis: a systematic review;428;Naranjo Síntes, Ramõn;Universidad de Granada, Department of Dermatology;Granada;;Spain;150;465;11;150
56;4;low quality;Sexual dysfunction in psoriasis: a systematic review;513;Ruiz-Carrascosa, José Carlos Arlos;Universidad de Granada, Department of Dermatology;Granada;;Spain;33;39;4;150
58;1;moderate quality;Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials;83;Carey, John J.;National University of Ireland Galway, Department of Rheumatology;Galway;;Ireland;41;233;9;76
58;2;moderate quality;Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials;112;Conway, Richard Gregory;University College Dublin, CARD Newman Research Fellow;Dublin;;Ireland;54;151;6;62
58;3;moderate quality;Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials;119;Coughlan, Robert J.;National University of Ireland Galway, Department of Rheumatology;Galway;;Ireland;72;809;15;150
58;4;moderate quality;Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials;360;Low, Candice;Connolly Hospital Blanchardstown, Department of Rheumatology;Dublin;;Ireland;7;42;3;5
58;5;moderate quality;Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials;441;O’Donnell, Martin J.;National University of Ireland Galway;Galway;;Ireland;170;14451;41;150
59;1;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;49;Bessette, Louis;Universite Laval, Department of Medicine;Quebec;;Canada;73;1702;23;150
59;2;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;55;Bissonnette, Robert T.;Innovaderm Research Inc.;Montreal;yes;Canada;127;2844;29;150
59;3;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;162;Dutz, Jan Peter;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;114;3307;31;150
59;4;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;182;Fleming, Patrick James;University of Toronto, Division of Dermatology;Toronto;;Canada;20;180;6;37
59;5;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;219;Gulliver, Wayne P F;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;86;2562;25;150
59;6;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;234;Haraoui, Boulos Paul;Universite de Montreal;Montreal;;Canada;150;5021;36;150
59;7;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;281;Keeling, Stephanie O.;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;19;194;8;111
59;8;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;294;Kraft, John N.;Lynde Centre for Dermatology;Markham;;Canada;19;296;8;30
59;9;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;366;Lynde, Charles W.;University of Toronto, Division of Dermatology;Toronto;;Canada;144;3585;31;150
59;10;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;399;McCourt, Collette;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;7;74;3;19
59;11;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;401;McFarlane, Alexandra;University of Alberta, Division of Rheumatology;Edmonton;;Canada;8;76;3;20
59;12;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;501;Richer, Vincent;St-Luc Hospital, Department of Medicine;Quebec;;Canada;14;81;4;32
59;13;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;510;Roubille, Camille;Universite de Montreal;Montreal;;Canada;35;310;9;106
59;14;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;574;Starnino, Tara;Universite de Montreal, Sacré-Coeur Hospital;Montreal;;Canada;7;74;3;19
59;15;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;477;Pope, Janet Elizabeth;Centre for Rheumatology, St Joseph's Health Centre;London;;United Kingdom;4;61;2;21
59;16;high quality;The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.;558;Siu, Stephanie;University of the West, Division of Rheumatology;London;;United Kingdom;6;71;3;17
60;1;low quality;Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review;30;Augustin, Matthias;Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat, Institute for Health Services Research in Dermatology and Nursing;Hamburg;;Germany;13;25;3;85
60;2;low quality;Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review;259;Jacobi, Arnd;Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat, Institute for Health Services Research in Dermatology and Nursing;Hamburg;;Germany;29;319;9;93
60;3;low quality;Keratolytics and Emollients and Their Role in the Therapy of Psoriasis: a Systematic Review;396;Mayer, Anke;Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat, German Center for Health Services Research in Dermatology (Cvderm);Hamburg;;Germany;11;54;5;104
61;1;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;135;De Jager, Michelle E A;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;16;254;10;27
61;2;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;136;De Jong, Elke M G J;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;3;9;1;21
61;3;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;419;Mul, Karlien;Radboud University Medical Center, Department of Neurology;Nijmegen;;Netherlands;11;24;3;68
61;4;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1190;19;150
61;5;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;657;13886;52;150
61;6;moderate quality;Systemic treatments in paediatric psoriasis: a systematic evidence-based update;627;Van Geel, Maartje J.;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;11;28;4;26
62;1;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;50;Betts, Keith A.;Analysis Group, Inc.;Boston;yes;United States;14;101;5;54
62;2;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;317;Lereun, Corinne M.;Analysis Group, Inc.;Boston;;United States;10;335;8;61
62;3;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;420;Mulani, Parvez M.;AbbVie, North Chicago;Chicago;yes;United States;59;1769;25;145
62;4;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;555;Signorovitch, James Edward;Analysis Group, Inc.;Boston;yes;United States;71;556;14;150
62;5;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;585;Sundaram, Murali;AbbVie, North Chicago;Chicago;yes;United States;20;165;6;68
62;6;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;666;Wu, Eric;Analysis Group, Inc.;Boston;;United States;13;25;4;59
62;7;moderate quality;Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response;684;Yan, Y. S.;Analysis Group, Inc.;Boston;;United States;2;40;2;11
63;1;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;32;Ayala., Fabio;Universita degli Studi di Napoli Federico II, Department of Dermatology;Naples;;Italy;288;2061;22;150
63;2;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;42;Balato, Nicola;Universita degli Studi di Napoli Federico II, Department of Clinical Medicine and Surgery;Naples;;Italy;245;1602;19;150
63;3;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;121;Crea, Filippo;Universita Cattolica del Sacro Cuore, Rome, Department of Cardiovascular Medicine;Rome;;Italy;46;51;5;150
63;4;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;149;Di Costanzo, Luisa;Universita degli Studi di Napoli Federico II, Department of Clinical Medicine and Surgery;Naples;;Italy;30;139;7;61
63;5;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;199;Gargiulo, Paola;IRCCS Fondazione SDN, Institute of Diagnostic and Nuclear Development;Naples;;Italy;38;383;10;150
63;6;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;417;Mosca, Susanna;Universita degli Studi di Napoli Federico II, Department of Advanced Biomedical Sciences;Naples;;Italy;9;54;4;46
63;7;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;454;Paolillo, Stefania;Istituto di Ricerca Diagnostica e Nucleare;Naples;;Italy;54;623 ;12;150
63;8;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;455;Parente, Antonio R.;Universita degli Studi di Napoli Federico II, Department of Advanced Biomedical Sciences;Naples;;Italy;21;224;7;98
63;9;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;466;Perrone Filardi, Pasquale;Universita degli Studi di Napoli Federico II, Department of Advanced Biomedical Sciences;Naples;;Italy;196;9251;34;150
63;10;low quality;Ischemic cardiovascular involvement in psoriasis: A systematic review;613;Trimarco, Bruno;Universita degli Studi di Napoli Federico II, Department of Advanced Biomedical Sciences;Naples;;Italy;557;9381;47;150
64;1;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;584;Sun, Qing;Shandong University, Department of Pathology;Jinan;;China;31;90;6;95
64;2;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;13;Almutawa, Fahad;Health Sciences Center Kuwait Faculty of Medicine, Department of Medicine;Safat;;Kuwait;8;92;5;18
64;3;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;239;Hekman, Daniel;Health Sciences Center Kuwait Faculty of Medicine, Department of Medicine;Safat;;Kuwait;2;12;2;9
64;4;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;602;Thalib, Lukman;Qatar University, Department of Public Health;Doha;;Qatar;123;1743;22;150
64;5;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;229;Hamzavi, Iltefat H.;Henry Ford Hospital, Department of Dermatology;Detroit;;United States;79;1379;22;150
64;6;moderate quality;Efficacy of localized phototherapy and photodynamic therapy for psoriasis: a systematic review and meta-analysis;344;Lim, Henry;Henry Ford Hospital, Department of Dermatology;Detroit;;United States;293;6657;39;150
65;1;high quality;Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis;260;Jacobs, Anja;Federal Joint Committee of the German Health Care System (G-BA);Berlin;;Germany;17;139;6;62
65;2;high quality;Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis;430;Nast, Alexander;Charite - Universitatsmedizin Berlin;Berlin;;Germany;116;2109;22;150
65;3;high quality;Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis;508;Rosumeck, Stefanie;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;37;690;11;112
65;4;high quality;Efficacy and Safety of Systemic Long-Term Treatments for Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis;653;Werner, Ricardo Niklas Iklas;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;19;114;6;101
66;1;high quality;Systematic review on the maintenance of response during systemic antipsoriatic therapy;260;Jacobs, Anja;Federal Joint Committee of the German Health Care System (G-BA);Berlin;;Germany;17;139;6;62
66;2;high quality;Systematic review on the maintenance of response during systemic antipsoriatic therapy;430;Nast, Alexander;Charite - Universitatsmedizin Berlin;Berlin;;Germany;116;2109;22;150
66;3;high quality;Systematic review on the maintenance of response during systemic antipsoriatic therapy;508;Rosumeck, Stefanie;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;37;690;11;112
67;1;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;100;Chen, Xiaoxiao;Guangzhou Medical University, Institute of Dermatology;Guangzhou;;China;3;1;1;20
67;2;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;334;Li, Wei;Zhengzhou University, Department of Physiology and Neurobiology;Zhengzhou;;China;7;3;1;41
67;3;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;341;Liang, Jingyao;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;4;4;1;23
67;4;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;364;Luo, Quan;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;1;1;1;8
67;5;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;609;Tian, Xin;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;6;8;2;43
67;6;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;714;Zhang, Fang;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;3;2;1;20
67;7;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;721;Zhang, Sanquan;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;25;169;5;66
67;8;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;724;Zhang, Xibao;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;6;5;1;29
67;9;moderate quality;Lack of association between cytotoxic T-lymphocyte antigen-4 + 49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case–control studies;728;Zhao, Tian;Guangzhou Institute of Dermatology, Department of Dermatology;Guangzhou;;China;5;2;1;31
68;1;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;124;Cui, Yong;Anhui Medical University, Institute of Dermatology and Department of Dermatology, Hefei;Hefei;;China;2;2;1;17
68;2;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;192;Gao, Jing;Anhui Medical University, Department of Dermatology;Hefei;;China;14;167;7;75
68;3;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;545;Shen, Changbing;Anhui Medical University, Collaborative Innovation Center for Complex and Severe Dermatosis;Hefei;;China;16;44;4;150
68;4;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;547;Sheng, Yujun;Anhui Medical University, Department of Dermatology;Hefei;;China;11;7;2;75
68;5;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;582;Sun, Liangdan;Anhui Medical University, Institute of Dermatology and Department of Dermatology, Hefei;Hefei;;China;1;2;1;6
68;6;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;725;Zhang, Xuejun;State Key Laboratory Incubation Base of Dermatology, Ministry of National Science and Technology;Hefei;;China;105;1473;19;150
68;7;low quality;Association of the Late Cornified Envelope-3 Genes with Psoriasis and Psoriatic Arthritis: A Systematic Review;701;Yin, Xianyong;The University of North Carolina at Chapel Hill, Department of Genetics;Chapel Hill;;United States;63;1330;15;150
69;1;low quality;Photodynamic therapy for psoriasis;5;Adelzadeh, Lily;David Geffen School of Medicine at UCLA;Los Angeles;;United States;5;11;2;6
69;2;low quality;Photodynamic therapy for psoriasis;107;Choi, Youngmike;Kaiser Permanente Medical Group, Department of Dermatology;San Francisco;;United States;7;6;2;9
69;3;low quality;Photodynamic therapy for psoriasis;667;Wu, Jashin J.;Kaiser Permanente, Department of Dermatology;San Francisco;;United States;151;1204;17;143
71;1;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
71;2;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
71;3;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;570;18;150
71;4;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;51;Beylot-Barry, Marie;Universite de Bordeaux;Bordeaux;;France;249;3631;32;150
71;5;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;80;Cantagrel, Alain;hôpital Pierre-Paul-Riquet, Service of Rheumatology;Toulouse;;France;265;6168;41;150
71;6;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
71;7;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
71;8;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
71;9;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
71;10;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
71;11;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275;39;150
71;12;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;28;150
71;13;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;511;Rouzaud, Marie;Universite de Bordeaux, Department of Dermatology;Bordeaux;;France;6;47;5;14
71;14;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;538;Sevrain, Morgane;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;7;47;5;16
71;15;moderate quality;Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis;634;Villani, Axel Patrice Atrice;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;27;63;6;54
72;1;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;49;Bessette, Louis;Universite Laval, Department of Medicine;Quebec;;Canada;73;1703;23;150
72;2;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;55;Bissonnette, Robert T.;Innovaderm Research Inc.;Montreal;yes;Canada;127;2846;29;150
72;3;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;162;Dutz, Jan Peter;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;174;3307;31;150
72;4;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;182;Fleming, Patrick James;University of Toronto, Division of Dermatology;Toronto;;Canada;20;180;6;37
72;5;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;219;Gulliver, Wayne P F;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;86;2562;25;150
72;6;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;234;Haraoui, Boulos Paul;Universite de Montreal;Montreal;;Canada;150;5023;36;150
72;7;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;281;Keeling, Stephanie O.;Memorial University of Newfoundland, Faculty of Medicine;St John's;;Canada;19;194;8;111
72;8;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;294;Kraft, John N.;Lynde Centre for Dermatology;Markham;;Canada;19;298;8;30
72;9;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;366;Lynde, CW W.;Lynde Centre for Dermatology;Markham;;Canada;3;66;2;29
72;10;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;399;McCourt, Collette;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;7;74;3;19
72;11;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;401;McFarlane, Alexandra;University of Alberta, Division of Rheumatology;Edmonton;;Canada;8;76;3;20
72;12;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;501;Richer, Vincent;St-Luc Hospital, Department of Medicine;Quebec;;Canada;14;81;4;32
72;13;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;510;Roubille, Camille;Universite de Montreal;Montreal;;Canada;35;310;9;106
72;14;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;574;Starnino, Tara;Universite de Montreal, Sacré-Coeur Hospital;Montreal;;Canada;7;74;3;19
72;15;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;477;Pope, Janet Elizabeth;Centre for Rheumatology, St Joseph's Health Centre;Tours;;United Kingdom;4;61;2;21
72;16;moderate quality;Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review;558;Siu, Stephanie;University of the West, Division of Rheumatology;London;;United Kingdom;6;71;3;17
73;1;moderate quality;Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases;430;Nast, Alexander;Charite - Universitatsmedizin Berlin;Berlin;;Germany;116;2114;22;150
73;2;moderate quality;Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases;508;Rosumeck, Stefanie;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;37;690;11;112
73;3;moderate quality;Biosimilars: a systematic review of published and ongoing clinical trials of antipsoriatics in chronic inflammatory diseases;535;Seidenschnur, Karin;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;1;1;1;2
74;1;moderate quality;Effect of tonsillectomy on psoriasis: A systematic review;135;De Jager, Michelle E A;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;16;254;10;27
74;2;moderate quality;Effect of tonsillectomy on psoriasis: A systematic review;136;De Jong, Elke M G J;Departments of Dermatology;Nijmegen;;Netherlands;200;3361;30;150
74;3;moderate quality;Effect of tonsillectomy on psoriasis: A systematic review;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1190;19;150
74;4;moderate quality;Effect of tonsillectomy on psoriasis: A systematic review;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;657;13886;52;150
75;1;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;120;Coyle, Meaghan E;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;23;241;9;40
75;2;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2568;24;150
75;3;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947;16;150
75;4;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;142;Deng, Jingwen;Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Dermatology;Guangzhou;;China;5;15;2;21
75;5;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;221;Guo, Xinfeng;Guangzhou University, Second Clinical Medical College;Guangzhou;;China;3;2;1;10
75;6;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
75;7;moderate quality;Acupuncture Therapies for Psoriasis Vulgaris: A Systematic Review of Randomized Controlled Trials;706;Yu, Jingjie;Guangdong Provincial Hospital of Traditional Chinese Medicine, Department of Dermatology;Guangzhou;;China;5;8;2;18
76;1;moderate quality;Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis;102;Chen, Yan;Kunming General Hospital of Chengdu Military Command, Department of Dermatology;Kunming;;China;2;5;1;8
76;2;moderate quality;Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis;233;Hao, Fei;Beihang University, Science and Technology on Aircraft Control Laboratory;Beijing;;China;220;2217;20;150
76;3;moderate quality;Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis;488;Qian, Tian;Third Military Medical University, Department of Dermatology;Chongqing;;China;5;5;1;18
76;4;moderate quality;Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis;682;Yan, Heng;Third Military Medical University, Department of Dermatology;Chongqing;;China;2;4;1;14
76;5;moderate quality;Clinical efficacy and safety of anti-IL-17 agents for the treatment of patients with psoriasis;713;Zhang, Dongmei;Third Military Medical University, Department of Dermatology;Chongqing;;China;417;3241;26;150
77;1;low quality;Clinical potential of brodalumab in the management of psoriasis: the evidence to date;36;Bagel, Jerry;Psoriasis Treatment Center of Central New Jersey;Windsor;;United States;36;932;16;150
77;2;low quality;Clinical potential of brodalumab in the management of psoriasis: the evidence to date;681;Yamauchi, Paul;David Geffen School of Medicine at UCLA, Division of Dermatology;Los Angeles;;United States;51;1534;21;95
83;1;high quality;Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: Systematic reviews of clinical effectiveness and cost-effectiveness;184;Frampton, Geoff K;University of Southampton, Faculty of Medicine;Southampton;;United Kingdom;60;1157;21;93
83;2;high quality;Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: Systematic reviews of clinical effectiveness and cost-effectiveness;276;Kalita, Neelam;University of Southampton, Southampton Health Technology Assessments Centre;Southampton;;United Kingdom;3;1;1;10
83;3;high quality;Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: Systematic reviews of clinical effectiveness and cost-effectiveness;359;Loveman, Emma;Effective Evidence LLP;Eastleigh;;United Kingdom;74;2106;22;92
83;4;high quality;Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: Systematic reviews of clinical effectiveness and cost-effectiveness;468;Pickett, Karen;University of Southampton, Southampton Health Technology Assessments Centre;Southampton;;United Kingdom;5;17;2;13
85;1;low quality;Dyslipidemia in dermatological disorders;494;Rao, Gururaja K.;Yenepoya Medical College, Departments of Endocrinolgy;Mangalore;;India;1;0;NA;2
85;2;low quality;Dyslipidemia in dermatological disorders;548;Shenoy, Chetana;Yenepoya Medical College, Department of Dermatology;Mangalore;;India;1;0;NA;2
85;3;low quality;Dyslipidemia in dermatological disorders;549;Shenoy, Manjunath Mala;Yenepoya Medical College, Department of Dermatology;Mangalore;;India;14;74;5;27
86;1;moderate quality;Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis;18;Anis, Aslam Hayat;St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences;Vancouver;;Canada;200;6676;45;150
86;2;moderate quality;Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis;256;Islam, Nazrul;The University of British Columbia, School of Population and Public Health;Vancouver;;Canada;8;2;10;150
86;3;moderate quality;Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis;369;Ma, Canice;St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences;Vancouver;;Canada;1;4;1;3
86;4;moderate quality;Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis;723;Zhang, Wei;The University of British Columbia, School of Population and Public Health;Vancouver;;Canada;8;858;2;22
88;1;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;365;Lv, Shichao;General Hospital of People's Liberation Army;Beijing;;Canada;1;0;NA;6
88;2;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;150;Diao, Jinfu;General Hospital of People's Liberation Army;Beijing;;China;1;0;NA;6
88;3;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;251;Huang, He;General Hospital of People's Liberation Army;Beijing;;China;1;0;NA;6
88;4;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;323;Li, Hengjin;General Hospital of People's Liberation Army, Department of Dermatology;Beijing;;China;22;73;4;70
88;5;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;325;Li, Jie;General Hospital of People's Liberation Army;Beijing;;China;1;0;NA;6
88;6;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;581;Sun, Lei;General Hospital of People's Liberation Army;Beijing;;China;1;0;NA;6
88;7;moderate quality;Evaluation of the Association Between CD143 Gene Polymorphism and Psoriasis;670;Xia, Tianbao;General Hospital of People's Liberation Army;Beijing;;China;1;0;NA;6
90;1;low quality;Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review;55;Boehncke, Wolf Henning;Hopitaux universitaires de Geneve, Division of Dermatology and Venereology;Geneve;;Switzerland;313;7333;43;150
90;2;low quality;Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review;387;Martinez, David Alvarez;Hopitaux universitaires de Geneve, Department of Dermatology;Geneve;;Switzerland;1;11;1;3
90;3;low quality;Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review;214;Gottlieb, Alice Bendix Endix;Tufts Medical Center, Department of Dermatology;Boston;;United States;313;18023;70;150
90;4;low quality;Safety and Efficacy of Therapies for Skin Symptoms of Psoriasis in Patients with Psoriatic Arthritis: A Systematic Review;567;Solomon, James A.;University of Illinois;Illinois;;United States;13;515;7;60
93;1;moderate quality;Psoriasis and risk of venous thromboembolism: A systematic review and meta-analysis;526;Sanguankeo, Anawin;Mahidol University, Department of Social and Preventive Medicine;Nakon Pathom;;Thailand;51;62;5;49
93;2;moderate quality;Psoriasis and risk of venous thromboembolism: A systematic review and meta-analysis;619;Upala, Sikarin;Mahidol University, Department of Social and Preventive Medicine;Nakon Pathom;;Thailand;49;50;5;48
93;3;moderate quality;Psoriasis and risk of venous thromboembolism: A systematic review and meta-analysis;579;Suksaranjit, Promporn;University of Utah, Division of Cardiovascular Medicine;Salt Lake City;;United States;32;84;4;75
93;4;moderate quality;Psoriasis and risk of venous thromboembolism: A systematic review and meta-analysis;618;Ungprasert, Patompong;Mayo Clinic, Department of Internal Medicine;Rochester;;United States;127;321;11;116
94;1;moderate quality;Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies;84;Carmona, Loreto;Instituto de Salud Musculoesquelética;Madrid;;Spain;215;10556;40;150
94;2;moderate quality;Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies;209;Gómez-Reino, Juan Jesús;Universidad de Santiago de Compostela, Facultad de Medicina, Department of Medicine;Santiago de Compostela;;Spain;309;14107;55;150
94;3;moderate quality;Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies;382;Maneiro, José Ramón Amon;Instituto de Investigación Ramón Domínguez, Rheumatology Unit;Santiago de Compostela;;Spain;15;163;7;13
94;4;moderate quality;Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies;520;Salgado, Eva;Universidad de Navarra, Department of Medicine;Pamplona;;Spain;18;182;8;15
94;5;moderate quality;Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies;570;Souto, Alejandro;Instituto de Investigación Ramón Domínguez, Rheumatology Unit;Santiago de Compostela;;Spain;13;114;6;83
97;1;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;49;Bessette, Louis;Universite Laval, Department of Medicine;Quebec;;Canada;73;1709;23;150
97;2;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;55;Bissonnette, Robert T.;Innovaderm Research Inc.;Montreal;yes;Canada;127;2854;29;150
97;3;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;162;Dutz, Jan Peter;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;113;3314;31;150
97;4;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;182;Fleming, Patrick James;University of Toronto, Division of Dermatology;Toronto;;Canada;20;180;6;37
97;5;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;219;Gulliver, Wayne P F;Memorial University of Newfoundland, Faculty of Medicine, Department of Medicine;St John's;;Canada;86;2567;25;150
97;6;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;234;Haraoui, Boulos Paul;Universite de Montreal;Montreal;;Canada;150;5033;36;150
97;7;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;281;Keeling, Stephanie O.;Memorial University of Newfoundland, Faculty of Medicine;St John's;;Canada;19;194;8;111
97;8;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;294;Kraft, John N.;Lynde Centre for Dermatology;Markham;;Canada;19;298;8;30
97;9;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;366;Lynde, Charles W.;University of Toronto, Division of Dermatology;Toronto;;Canada;143;3580;31;150
97;10;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;399;McCourt, Collette;The University of British Columbia, Department of Dermatology and Skin Science;Vancouver;;Canada;7;74;3;19
97;11;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;401;McFarlane, Alexandra;University of Alberta, Division of Rheumatology;Edmonton;;Canada;8;76;3;20
97;12;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;477;Pope, Janet Elizabeth;Western University, Department of Medicine;London;;Canada;198;6886;39;150
97;13;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;501;Richer, Vincent;St-Luc Hospital, Department of Medicine;Quebec;;Canada;14;81;4;32
97;14;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;510;Roubille, Camille;Universite de Montreal;Montreal;;Canada;35;311;9;106
97;15;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;574;Starnino, Tara;Universite de Montreal, Sacré-Coeur Hospital;Montreal;;Canada;7;74;3;19
97;16;moderate quality;Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: Expert opinion of the canadian dermatology-rheumatology comorbidity initiative;558;Siu, Stephanie;University of the West, Division of Rheumatology;London;;United Kingdom;6;71;3;17
103;1;moderate quality;Four polymorphisms of VEGF (+405C>G,-460T>C,-2578C>A, and-1154G>A) in susceptibility to psoriasis: A meta-analysis;253;Huang, Xiaoyuan;Huazhong University of Science and Technology, Reproductive Medicine Center;Wuhan;;China;116;458;11;150
103;2;moderate quality;Four polymorphisms of VEGF (+405C>G,-460T>C,-2578C>A, and-1154G>A) in susceptibility to psoriasis: A meta-analysis;487;Qi, Min;Xiangya Hospital of Central-south University, Department of Plastic and Cosmetic Surgery;Changsha;;China;11;37;4;30
103;3;moderate quality;Four polymorphisms of VEGF (+405C>G,-460T>C,-2578C>A, and-1154G>A) in susceptibility to psoriasis: A meta-analysis;717;Zhang, Jianglin;Xiangya Hospital of Central-south University, Department of Dermatology;Changsha;;China;12;91;5;61
103;4;moderate quality;Four polymorphisms of VEGF (+405C>G,-460T>C,-2578C>A, and-1154G>A) in susceptibility to psoriasis: A meta-analysis;733;Zhou, Lei;Beijing Key Laboratory of POCT for Bioemergency and Clinic (No. BZ0329);Beijing;;China;78;1200;21;150
104;5;moderate quality;Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis;250;Hu, Li;Xi'an Jiaotong University, School of Medicine, Department of Immunology and Pathogenic Biology; Xi'an;;China;12;81;6;11
104;1;moderate quality;Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis;371;Ma, Junxian;Xi'an Jiaotong University, Department of Immunology and Pathogenic Biology; Xi'an;;China;9;39;4;14
104;2;moderate quality;Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis;674;Xiao, Shengxiang;Xi'an Jiaotong University, Department of Dermatology; Xi'an;;China;62;186;6;149
104;3;moderate quality;Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis;729;Zhao, Ya E.;Xi'an Jiaotong University, Department of Immunology and Pathogenic Biology; Xi'an;;China;23;244;11;32
104;4;moderate quality;Investigation of the association between psoriasis and human leucocyte antigens A by means of meta-analysis;730;Zhao, Yaling;Kunming Medical University, Department of Obstetrics and Gynecology,;Kunming;;China;17;49;4;57
105;1;low quality;Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity andpsychological burden in patients treated with biological therapies;114;Corey, Kristen C.;University of Massachusetts System, Department of Dermatology;Boston;;United States;9;52;4;25
105;2;low quality;Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity andpsychological burden in patients treated with biological therapies;286;Kimball, Alexa Boer Oer;Massachusetts General Hospital, Department of Dermatology;Boston;;United States;223;6284;39;150
105;3;low quality;Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): The correlation between disease severity andpsychological burden in patients treated with biological therapies;392;Mattei, Peter L.;Johns Hopkins University, Department of Dermatology;Baltimore;;United States;5;89;4;12
106;1;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;236;Haufe, Eva;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;23;84;4;106
106;2;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;430;Nast, Alexander;Charite - Universitatsmedizin Berlin;Berlin;;Germany;116;2126;22;150
106;3;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;508;Rosumeck, Stefanie;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;37;697;11;112
106;4;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;531;Schmitt, Jochen M.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;167;3323;33;150
106;5;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;571;Sporbeck, Birte;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;19;155;6;99
106;6;moderate quality;Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: Meta-analysis of randomized controlled trials;605;Thomaschewski, G.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;1;51;1;5
107;1;moderate quality;Psoriasis and smoking: A systematic review and meta-analysis;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
107;2;moderate quality;Psoriasis and smoking: A systematic review and meta-analysis;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1978;24;150
107;3;moderate quality;Psoriasis and smoking: A systematic review and meta-analysis;148;Dhillon, Jaskaran S.;UC Davis, Department of Dermatology;Davis;;United States;4;56;4;11
107;4;moderate quality;Psoriasis and smoking: A systematic review and meta-analysis;235;Harskamp, Caitlin T.;UC Davis, Department of Dermatology;Davis;;United States;20;539;9;18
108;1;moderate quality;Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review;1;Aas, Eline;Universitetet i Oslo, Faculty of Medicine;Oslo;;Norway;24;202;7;80
108;2;moderate quality;Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review;227;Hagen, Kåre Birger;Universitetet i Oslo, National Advisory Unit on Rehabilitation in Rheumatology;Oslo;;Norway;156;3801;35;150
108;3;moderate quality;Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review;295;Krogstad, Anne Lene;Oslo University Hospital, Department of Dermatology;Oslo;;Norway;43;711;15;87
108;4;moderate quality;Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review;309;Larsen, Marie Hamilton Amilton;Oslo University Hospital, Section for Climate Therapy;Oslo;;Norway;7;27;3;8
108;5;moderate quality;Limited evidence of the effects of patient education and self-management interventions in psoriasis patients: A systematic review;636;Wahl, Astrid Klopstad;Universitetet i Oslo, Department of Health Sciences;Oslo;;Norway;119;2176;26;150
109;1;moderate quality;Antidrug antibodies in psoriasis: A systematic review;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
109;2;moderate quality;Antidrug antibodies in psoriasis: A systematic review;249;Hsu, Leeyen;UC Davis, Department of Dermatology;Davis;;United States;10;211;8;20
109;3;moderate quality;Antidrug antibodies in psoriasis: A systematic review;564;Snodgrass, Brett Thomas;DrSocial Ltd.;Beverly Hills;;United States;5;47;3;4
110;1;moderate quality;Topical herbal formulae in the management of psoriasis: Systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs;143;Deng, Shiqiang;Royal Melbourne Institute of Technology University, School of Health Sciences;Melbourne;;Australia;7;52;5;5
110;2;moderate quality;Topical herbal formulae in the management of psoriasis: Systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;50;255;10;75
110;3;moderate quality;Topical herbal formulae in the management of psoriasis: Systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;177;2579;24;150
110;4;moderate quality;Topical herbal formulae in the management of psoriasis: Systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;96;950;16;150
110;5;moderate quality;Topical herbal formulae in the management of psoriasis: Systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;81;239;8;150
111;1;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;54;Binzhu, L;Guangxi Medical University;Nanning;;China;1;11;1;8
111;2;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;154;Dongmei, L.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;3;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;269;Jianmin, L.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;4;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;271;Jinju, F.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;5;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;403;Meile, T.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;6;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;404;Meng, Y;Guangxi Medical University;Nanning;;China;1;11;1;8
111;7;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;472;Ping, T.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;8;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;671;Xiao, H.;Guangxi Medical University;Nanning;;China;1;11;1;8
111;9;high quality;Systematic review and meta-analysis of ustekinumab for moderate to severe psoriasis;686;Yanbin, P.;Guangxi Medical University;Nanning;;China;1;11;1;8
112;1;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
112;2;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
112;3;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;753;18;150
112;4;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;51;Beylot-Barry, Marie;Universite de Bordeaux;Bordeaux;;France;249;3636;32;150
112;5;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;80;Cantagrel, Alain;hôpital Pierre-Paul-Riquet, Service of Rheumatology;Toulouse;;France;265;6175;41;150
112;6;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
112;7;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
112;8;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
112;9;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
112;10;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
112;11;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
112;12;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
112;13;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;511;Rouzaud, Marie;Universite de Bordeaux, Department of Dermatology;Bordeaux;;France;6;47;5;14
112;14;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;538;Sevrain, Morgane;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;7;47;5;16
112;15;moderate quality;Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review;634;Villani, Axel Patrice Atrice;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;27;63;6;54
113;1;moderate quality;Combined use of systemic agents for psoriasis: A systematic review ;74;Busard, Celine;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;1;6;1;4
113;2;moderate quality;Combined use of systemic agents for psoriasis: A systematic review ;304;Langendam, Miranda W.;Academic Medical Centre, University of Amsterdam, Department of Clinical Epidemiology;Amsterdam;;Netherlands;55;1250;22;150
113;3;moderate quality;Combined use of systemic agents for psoriasis: A systematic review ;345;Limpens, Jacqueline;Academic Medical Centre, University of Amsterdam, Medical Library;Amsterdam;;Netherlands;27;398;11;88
113;4;moderate quality;Combined use of systemic agents for psoriasis: A systematic review ;572;Spuls, Phyllis Ira;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;105;3101;27;150
113;5;moderate quality;Combined use of systemic agents for psoriasis: A systematic review ;740;Zweegers, Jeffrey;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;18;114;6;59
114;1;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;187;Gaeta, Giovanni Battista Attista;Seconda Universita degli Studi di Napoli, Italy Department of Internal Medicine and Specialist Units;Naples;;Italy;226;5095;35;150
114;2;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;482;Prignano, Francesca;Universita degli Studi di Firenze, Department of Surgery and Translational Medicine;Florence;;Italy;115;787;16;150
114;3;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;55;Boccia, Stefania;Universita Cattolica del Sacro Cuore, Rome, Faculty of Medicine;Rome;;Italy;178;2323;27;150
114;4;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;81;Cantini, Fabrizio;Ospedale Misericordia e Dolce, Prato, Division of Rheumatology;Prato;;Italy;186;5893 ;45;150
114;5;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;207;Goletti, Delia;IRCCS Istituto Nazionale Malattie Infettive Lazzaro Spallanzani, Department of Epidemiology;Rome;;Italy;123;4604;39;150
114;6;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;254;Iannone, Florenzo;Universita degli Studi di Bari, Interdisciplinary Department of Medicine;Bari;;Italy;158;2462;25;150
114;7;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;316;Leoncini, Emanuele;Alessandra Lisi International Centre on Birth Defects and Prematurity;Rome;;Italy;63;703;15;150
114;8;low quality;HBV reactivation in patients treated with antitumor necrosis factor-alpha (TNF- α) agents for rheumatic and dermatologic conditions: Asystematic review and meta-analysis;453;Panić, Nikola;University of Belgrade, Faculty of Medicine;Belgrade;;Serbia;25;146;5;108
115;1;moderate quality;Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials with different time points;196;García, Ignacio J.;Instituto Universitario de Oncologia del Principado de Asturias, Departamento de Biología Funcional;Oviedo;;Spain;38;417;12;119
115;2;moderate quality;Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials with different time points;357;López, Antonio Morales;Universitat Autònoma de Barcelona, Department of Dermatology;Barcelona;;Spain;11;82;5;76
115;3;moderate quality;Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials with different time points;484;Puig, Lluís L.;Universitat Autònoma de Barcelona, Department of Dermatology;Barcelona;;Spain;282;3535;29;150
115;4;moderate quality;Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials with different time points;633;Vilarrasa, Eva;Universitat Autònoma de Barcelona, Department of Dermatology;Barcelona;;Spain;15;100;5;37
116;5;moderate quality;Network meta-analysis of treatments for chronic plaque psoriasis in Canada  ;129;Daigle, Deanne;Mediprobe Research Inc., ;London;yes;Canada;22;42;5;25
116;6;moderate quality;Network meta-analysis of treatments for chronic plaque psoriasis in Canada  ;224;Gupta, Aditya K.;Mediprobe Research Inc., ;London;yes;Canada;542;17349;71;150
116;7;moderate quality;Network meta-analysis of treatments for chronic plaque psoriasis in Canada  ;367;Lyons, Danika C A;Western University, Department of Anatomy and Cell Biology The Schulich School of Medicine and Dentistry;London;;Canada;11;32;3;21
119;1;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;49;249;10;74
119;2;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;457;Parker, Shefton J;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;8;16;3;18
119;3;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2567;24;150
119;4;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947;16;150
119;5;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;712;Zhang, Claireshuiqing;Royal Melbourne Institute of Technology University, School of Biomedical Sciences;Melbourne;;Australia;19;73;6;30
119;6;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
119;7;high quality;Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: A systematic review;705;Yu, Jasonjingjie;Guangdong Provincial Hospital of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;5;13;2;11
120;1;high quality;Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies;47;Barker, Jonathan N. W. N.;King's College London, Division of Genetics and Molecular Medicine;London;;United Kingdom;291;14593;62;150
120;2;high quality;Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies;147;Dhillon, Amar Paul Aul;UCL Medical School, Department of Cellular Pathology;London;;United Kingdom;36;788;13;129
120;3;high quality;Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies;257;Jabbar-Lopez, Zarif K.;Royal Victoria Infirmary, Department of Dermatology;Melbourne;;United Kingdom;4;16;2;8
120;4;high quality;Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies;395;Maybury, Catriona M.;Guy's and St Thomas' NHS Foundation Trust;Guangzhou;;United Kingdom;12;25;2;19
120;5;high quality;Methotrexate and liver fibrosis in people with psoriasis: A systematic review of observational studies;662;Wong, Terry;NHS Foundation Trust, Department of Gastroenterology;Leeds;;United Kingdom;48;854;16;125
121;1;high quality;Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: A systematic review and meta-analysis;47;Barker, Jonathan N. W. N.;King's College London, Division of Genetics and Molecular Medicine;London;;United Kingdom;291;14593;62;150
121;2;high quality;Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: A systematic review and meta-analysis;157;Douiri, A.;King's College London, Division of Health and Social Care Research;London;;United Kingdom;73;1169;19;150
121;3;high quality;Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: A systematic review and meta-analysis;395;Maybury, Catriona M.;Guy's and St Thomas' NHS Foundation Trust;London;;United Kingdom;12;25;2;19
121;4;high quality;Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: A systematic review and meta-analysis;521;Samarasekera, Eleanor J.;Royal College of Physicians;London;;United Kingdom;7;125;5;14
121;5;high quality;Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: A systematic review and meta-analysis;561;Smith, Catherine H.;Guy's and St Thomas' NHS Foundation Trust;London;;United Kingdom;127;4888;35;150
122;1;high quality;The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.;23;Arends, Lidia R.;Erasmus University Medical Center, Department of Pulmonary Medicine;Rotterdam;;Netherlands;71;3079;27;150
122;2;high quality;The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.;158;Dowlatshahi, Emmilia Assal;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;11;211;7;29
122;3;high quality;The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.;436;Nijsten, Tamar E C;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;247;5705;37;150
122;4;high quality;The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.;637;Wakkee, Marlies;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;26;521;11;42
124;1;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;22;Ardabili, Michael;Universitat Bochum, Department of Dermatology;Bochum;;Germany;3;30;3;12
124;2;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;30;Augustin, Matthias;Universitatsklinikum Hamburg-Eppendorf und Medizinische Fakultat;Hamburg;;Germany;357;4691;37;150
124;3;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;55;Bonnekoh, Bernd;Otto von Guericke University of Magdeburg;Magdeburg;;Germany;122;1534;22;150
124;4;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;418;Mrowietz, Ulrich;Universitatsklinikum Schleswig-Holstein Campus Kiel, Psoriasis-Center at the Department of Dermatology;Kiel;;Germany;258;7879;50;150
124;5;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;497;Reich, Kristian;Dermatologikum Hamburg;Hamburg;;Germany;242;9358;53;150
124;6;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;498;Reusch, Michael K.;Dermatological Practice am Tibarg;Hamburg;;Germany;42;280;10;100
124;7;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;506;Rosenbach, Thomas;Dermatological Practice;Osnabruck;;Germany;20;696;10;80
124;8;low quality;Topical long-term therapy of psoriasis with vitamin D3 analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice;601;Thaçi, Diamant;Universitatskliniken Schleswig-Holstein, Comprehensive Center for Inflammation Medicine;Kiel;;Germany;110;2401;25;150
125;1;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
125;2;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
125;3;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;753;18;150
125;4;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;51;Beylot-Barry, Marie;Universite de Bordeaux;Bordeaux;;France;249;3636;32;150
125;5;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;80;Cantagrel, Alain;hôpital Pierre-Paul-Riquet, Service of Rheumatology;Toulouse;;France;265;6175;41;150
125;6;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
125;7;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
125;8;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
125;9;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
125;10;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
125;11;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
125;12;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
125;13;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;511;Rouzaud, Marie;Universite de Bordeaux, Department of Dermatology;Bordeaux;;France;6;47;5;14
125;14;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;538;Sevrain, Morgane;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;7;47;5;16
125;15;moderate quality;Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: Systematic review and expert opinion;634;Villani, Axel Patrice Atrice;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;27;63;6;54
126;1;moderate quality;The prevalence of onychomycosis in psoriatic patients: A systematic review;161;Dulak, Maria G.;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;2;12;1;10
126;2;moderate quality;The prevalence of onychomycosis in psoriatic patients: A systematic review;292;Klaassen, Karlijn M G;Dermatoloog;Nijmegen;;Netherlands;9;66;5;8
126;3;moderate quality;The prevalence of onychomycosis in psoriatic patients: A systematic review;459;Pasch, Marcel Christian;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;57;493;14;112
126;4;moderate quality;The prevalence of onychomycosis in psoriatic patients: A systematic review;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;62;869;13;150
127;1;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);38;Bai, Yanping;China-Japan Friendship Hospital, Department of Dermatology and Venereology;Beijing;;China;15;58;5;60
127;2;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);96;Chen, Jing;Capital Medical University China;Beijing;;China;1;3;1;19
127;3;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);98;Chen, Weiwen;Capital Medical University China;Beijing;;China;2;5;2;25
127;4;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);141;Deng, Bingxu;Capital Medical University China;Beijing;;China;2;5;2;25
127;5;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);160;Duan, Yiqun;Wuhan Hospital of Integrated Chinese and Western Medicine;Wuhan;;China;1;3;1;19
127;6;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);266;Jiang, Chunyan;Capital Medical University China;Beijing;;China;10;246;3;53
127;7;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);331;Li, Ping;Capital Medical University China;Beijing;;China;2;4;1;25
127;8;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);337;Li, Xun;Beijing University of Chinese Medicine;Beijing;;China;3;4;1;45
127;9;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);350;Liu, Jianping;Beijing University of Chinese Medicine, Center for Evidence-Based Chinese Medicine;Beijing;;China;293;2407;24;150
127;10;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);353;Liu, Wali;China Academy of Chinese Medical Sciences, Department of Dermatology;Beijing;;China;15;29;3;61
127;11;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);490;Qu, Jianhua;Capital Medical University China;Beijing;;China;1;3;1;19
127;12;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);491;Qu, Xing;Beijing University of Chinese Medicine;Beijing;;China;5;8;2;31
127;13;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);583;Sun, Liyun;Beijing Traditional Chinese Medicine Hospital, Department of Dermatology;Beijing;;China;4;5;2;31
127;14;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);643;Wang, Ping;Capital Medical University China, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis;Beijing;;China;13;79;3;90
127;15;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);675;Xu, Jia;Capital Medical University China, Beijing Youan Hospital;Beijing;;China;3;8;2;23
127;16;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);678;Xu, Wenjie;Capital Medical University China;Beijing;;China;1;3;1;19
127;17;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);696;Yang, Zhibo;Hunan University;Changsha;;China;1;3;1;19
127;18;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);710;Zhang, Cang;Capital Medical University China;Beijing;;China;1;3;1;19
127;19;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);715;Zhang, Guangzhong;Capital Medical University China;Beijing;;China;1;5;2;31
127;20;moderate quality;Evidence-based practice guideline of Chinese herbal medicine for psoriasis vulgaris (Bai Bi);731;Zhou, Dongmei;Beijing Traditional Chinese Medicine Hospital, Department of Dermatology;Beijing;;China;4;5;2;31
128;1;moderate quality;Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: A systematic review of published models and clinical practice guidelines;378;Mallya, Usha G.;Novartis Pharma;Rueil-Malmaison;yes;France;10;83;6;46
128;2;moderate quality;Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: A systematic review of published models and clinical practice guidelines;524;Samuel, Miny;Yong Loo Lin School of Medicine, Singapore City;Mangalore;;Singapore;41;980;17;82
128;3;moderate quality;Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: A systematic review of published models and clinical practice guidelines;398;McBride, Doreen;RTI Health Solutions, Research Triangle Park;Newcastle;yes;United Kingdom;8;83;3;25
128;4;moderate quality;Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: A systematic review of published models and clinical practice guidelines;175;Feldman, Steven R.;Wake Forest Baptist Health;Winston Salem;;United States;812;16636;59;150
128;5;moderate quality;Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: A systematic review of published models and clinical practice guidelines;393;Mauskopf, Josephine A.;RTI Health Solutions, Research Triangle Park;Manchester;yes;United States;139;3622;34;150
129;1;low quality;Characterization of health-related quality of life studies in people with psoriasis: Systematic review 2003–2013;82;Cardona Arias, Jaiberth Antonio;Cooperative University of Colombia, School of Medicine;Medellin;;Colombia;38;24;3;64
129;2;low quality;Characterization of health-related quality of life studies in people with psoriasis: Systematic review 2003–2014;185;Franco-Aguirre, John Querubín;Universidad de Antioquia, Grupo Salud y Sosteniblidad;Medellin;;Colombia;4;0;NA;3
130;1;low quality;Systemic Therapies for Psoriasis: An Evidence-Based Update;175;Feldman, Steven R.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;812;16583;59;150
130;2;low quality;Systemic Therapies for Psoriasis: An Evidence-Based Update;470;Pierce, Allison;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;2;6;1;3
130;3;low quality;Systemic Therapies for Psoriasis: An Evidence-Based Update;525;Sandoval, Laura F;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;32;101;5;39
131;1;low quality;A Systematic Review of Systemic Medications for Pustular Psoriasis in Pediatrics;308;Lara-Corrales, Irene;Hospital for Sick Children University of Toronto, Division of Paediatric Medicine;Toronto;;Canada;40;383;10;125
131;2;low quality;A Systematic Review of Systemic Medications for Pustular Psoriasis in Pediatrics;476;Pope, Elena;Hospital for Sick Children University of Toronto, Department of Pediatrics;Toronto;;Canada;108;1913;22;150
131;3;low quality;A Systematic Review of Systemic Medications for Pustular Psoriasis in Pediatrics;478;Posso-De Los Rios, Claudia J.;Hospital for Sick Children University of Toronto, Division of Paediatric Medicine;Toronto;;Canada;6;18;2;8
132;1;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;9;Ali, Shozab S.;University of Manchester School of Medicine, Manchester,;Manchester;;United Kingdom;11;40;4;48
132;2;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;6;Agatston, Arthur S;Florida International University, Department of Medicine;Miami;;United States;99;5635;23;150
132;3;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;55;Blumenthal, Roger S;The Johns Hopkins School of Medicine, Ciccarone Center for the Prevention of Heart Disease;Baltimore;;United States;523;16300;60;150
132;4;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;69;Budoff, Matthew Jay;Los Angeles County Harbor-UCLA Med Center, Department of Cardiology;Torrance;;United States;770;23364;74;150
132;5;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;125;Cury, Ricardo Caldeira;Baptist Hospital Miami;Miami;;United States;225;8106;47;150
132;6;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;178;Fialkow, Jonathan;Center for Healthcare Advancement and Outcomes, Baptist Health Medical Group;Miami;;United States;8;247;6;47
132;7;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;261;Jamal, Omar;Center for Healthcare Advancement and Outcomes, Baptist Health Medical Group;Miami;;United States;7;29;3;37
132;8;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;279;Karim, Adil;Center for Prevention and Wellness Research, Baptist Health Medical Group;Miami;;United States;3;25;3;18
132;9;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;400;Mcevoy, John W;The Johns Hopkins School of Medicine, Department of Medicine;Baltimore;;United States;62;544;10;150
132;10;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;429;Nasir, Khurram;Johns Hopkins University;Baltimore;;United States;394;12955;56;150
132;11;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;443;Oni, Ebenezer T;Icahn School of Medicine at Mount Sinai, Department of Medicine;New York;;United States;9;107;5;32
132;12;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;541;Shaharyar, Sameer;Baptist Health South Florida, Center for Healthcare Advancement and Outcomes;Miami;;United States;11;37;4;57
132;13;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;649;Warraich, Haider Javed Aved;Duke University Health System, Department of Medicine;Durham;;United States;41;350;12;92
132;14;low quality;Subclinical cardiovascular disease in plaque psoriasis: Association or causal link?;55;Blaha, Michael J.;Johns Hopkins Hospital, Ciccarone Center for the Prevention of Heart Disease;Baltimore;;United States;258;7544;32;150
136;1;low quality;The economic burden of psoriasis: a systematic literature review;378;Mallya, Usha G.;Novartis Pharma;;yes;France;10;83;6;46
136;2;low quality;The economic burden of psoriasis: a systematic literature review;73;Burudpakdee, Chakkarin;The University of North Carolina at Charlotte;Charlotte;;United States;9;51;4;39
136;3;low quality;The economic burden of psoriasis: a systematic literature review;175;Feldman, Steven R;Wake Forest Baptist Health;Winston Salem;;United States;812;16583;59;150
136;4;low quality;The economic burden of psoriasis: a systematic literature review;188;Gala, Smeet;Valid Insight;London;yes;United States;6;11;1;15
136;5;low quality;The economic burden of psoriasis: a systematic literature review;427;Nanavaty, Merena;MKTXS Market Access Solutions, LLC.;Raritan;yes;United States;4;11;1;14
137;1;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
137;2;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
137;3;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;753;18;150
137;4;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;51;Beylot-Barry, Marie;Universite de Bordeaux;Bordeaux;;France;249;3636;32;150
137;5;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;80;Cantagrel, Alain;hôpital Pierre-Paul-Riquet, Service of Rheumatology;Toulouse;;France;265;6175;41;150
137;6;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
137;7;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
137;8;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
137;9;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
137;10;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
137;11;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
137;12;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
137;13;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;511;Rouzaud, Marie;Universite de Bordeaux, Department of Dermatology;Bordeaux;;France;6;47;5;14
137;14;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;538;Sevrain, Morgane;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;7;47;5;16
137;15;moderate quality;Treatment for palmoplantar pustular psoriasis: Systematic literature review, evidence-based recommendations and expert opinion;634;Villani, Axel Patrice Atrice;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;27;63;6;54
138;1;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
138;2;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;29;Aubin, François J;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
138;3;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;750;18;150
138;4;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;51;Beylot-Barry, Marie;Universite de Bordeaux;Bordeaux;;France;249;3631;32;150
138;5;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;80;Cantagrel, Alain;hôpital Pierre-Paul-Riquet, Service of Rheumatology;Toulouse;;France;265;6168;41;150
138;6;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
138;7;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
138;8;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
138;9;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
138;10;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
138;11;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275;39;150
138;12;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;25;150
138;13;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;511;Rouzaud, Marie;Universite de Bordeaux, Department of Dermatology;Bordeaux;;France;6;47;5;14
138;14;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;538;Sevrain, Morgane;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;7;47;5;16
138;15;low quality;Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus;634;Villani, Axel Patrice Atrice;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;27;63;6;54
139;1;low quality;Biologic systemic therapy for moderate-to-severe psoriasis: A review;8;Al-Hoqail, Ibrahim A.;King Saud bin Abdulaziz University for Health Sciences, Department of Basic Medical Science;Riyadh;;Saudi Arabia;18;186;8;31
139;2;low quality;Biologic systemic therapy for moderate-to-severe psoriasis: A review;423;Mustafa, Ali Ahmed;King Saud bin Abdulaziz University for Health Sciences, Department of Basic Medical Science;Riyadh;;Saudi Arabia;1;3;1;1
140;1;moderate quality;The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: A systematic review of the literature with a meta-analysis;140;Demengeot, J.;Instituto Gulbenkian de Ciencia;Oeiras;;Portugal;56;4309;29;150
140;2;moderate quality;The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: A systematic review of the literature with a meta-analysis;194;Garcês, Sandra;Hospital Garcia de Orta, Department of Rheumatology;Almada;;Portugal;11;211;7;150
140;3;moderate quality;The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: A systematic review of the literature with a meta-analysis;48;Benito-Garcia, Elizabeth;Roche Pharmaceuticals Division;Basel;yes;Switzerland;9;359;7;62
141;1;moderate quality;Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis;265;Jia, Y.;Henan University of Science and Technology, First Affiliated Hospital;Luoyang;;China;1;2;1;4
141;2;moderate quality;Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis;326;Li, L. J.;Henan University of Science and Technology, First Affiliated Hospital;Luoyang;;China;1;2;1;4
141;3;moderate quality;Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis;354;Liu, Xiaoli;Shenzhen University, College of Optoelectronic Engineering, Qingshuihe;Shenzhen;;China;597;5296;30;150
141;4;moderate quality;Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis;489;Qin, Haojie;Henan University of Science and Technology, Department of Forensic Pathology, ;Luoyang;;China;17;68;6;45
141;5;moderate quality;Association of the tumour necrosis factor-α polymorphisms rs361525 and rs1800629 with susceptibility to psoriasis: A meta-analysis;716;Zhang, J. X.;Henan University of Science and Technology, First Affiliated Hospital;Luoyang;;China;1;2;1;4
142;1;high quality;Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors;165;Ellervik, Christina;Nykobing F. Sygehus, Department of Research;Nykobing Falster;;Denmark;61;901;16;120
142;2;high quality;Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors;263;Jemec, Gregor B.E.;Kobenhavns Universitet, Department of Dermatology;Copenhagen;;Denmark;438;7834;48;150
142;3;high quality;Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors;410;Miller, Iben Marie;Faculty of Health and Medical Sciences;Copenhagen;;Denmark;30;263;8;47
142;4;high quality;Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors;698;Yazdanyar, Shiva;Kobenhavns Universitet, Department of Clinical Biochemistry;Copenhagen;;Denmark;19;288;8;30
143;1;moderate quality;Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis;31;Aviña-Zubieta, Juan Antonio;The University of British Columbia, Department of Medicine;Vancouver;;Canada;49;1359;20;150
143;2;moderate quality;Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis;159;Druyts, Eric F.;Precision Global Health;Vancouver;;Canada;44;535;14;115
143;3;moderate quality;Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis;411;Mills, Edward J.;Global Evaluative Sciences;Vancouver;;Canada;355;12344;56;150
143;4;moderate quality;Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: An indirect comparison meta-analysis;607;Thorlund, Kristian;Precision Global Health;Vancouver;yes;Canada;111;3909;30;150
144;1;high quality;Topical treatments for chronic plaque psoriasis;19;Anne R. Masson;University of York, Centre for Health Economics;York;;United Kingdom;65;1426;17;114
144;2;high quality;Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review;115;Cork, Michael J.;Academic Unit of Dermatology Research, Department of Infection and Immunity, The University of Sheffield;Sheffiel;;United Kingdom;2;9;1;30
144;3;high quality;Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review;155;Dooley, Gordon;Metaxis Ltd,;Curbridge;yes;United Kingdom;9;260;7;31
144;4;high quality;Topical treatments for chronic plaque psoriasis;212;Gordon Dooley;Metaxis Ltd,;Curbridge;yes;United Kingdom;9;260;7;31
144;5;high quality;Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review;231;Hancock, Helen C.;University of Durham, Durham Clinical Trials Unit;Durham;;United Kingdom;29;277;11;51
144;6;high quality;Topical treatments for chronic plaque psoriasis;240;Helen C. Hancock;University of Durham, Durham Clinical Trials Unit;Durham;;United Kingdom;29;277;11;51
144;7;high quality;Topical treatments for chronic plaque psoriasis;262;James Mason;Warwick Medical School -Health Sciences,University of Warwick;Coventry;;United Kingdom;205;7998;40;150
144;8;high quality;Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review;389;Mason, Anne R.;University of York, Centre for Health Economics;York;;United Kingdom;65;1426;17;114
144;9;high quality;Topical treatments for chronic plaque psoriasis: An abridged Cochrane Systematic Review;390;Mason, J. M.;Warwick Medical School -Health Sciences,University of Warwick;Coventry;;United Kingdom;205;7998;40;150
144;10;high quality;Topical treatments for chronic plaque psoriasis;409;Michael Cork;Academic Unit of Dermatology Research, Department of Infection and Immunity, The University of Sheffield;Sheffiel;;United Kingdom;2;9;1;30
146;1;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;116;Correr, Cassyano Januário;Universidade Federal do Parana, Department of Pharmacy;Curitiba;;Brazil;71;513;12;104
146;2;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;197;Garcia, Mariana Martins Artins;Universidade Federal do Parana;Curitiba;;Brazil;2;4;2;11
146;3;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;205;Godoy, Rangel Ray Ay;Universidade Federal do Parana;Curitiba;;Brazil;2;2;1;10
146;4;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;210;Gonçalves, Patrícia Rodrigues;Universidade Federal do Parana;Curitiba;;Brazil;3;27;2;12
146;5;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;448;Otuki, Michel Fleith Leith;Universidade Federal do Parana, Department of Pharmacology;Curitiba;;Brazil;68;1304;18;150
146;6;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;504;Riveros, Bruno Salgado Algado;Universidade Federal do Parana, Post Graduation Department;Curitiba;;Brazil;4;13;2;12
146;7;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;509;Rotta, Inajara;Universidade Federal do Parana, Post-Graduate Program of Pharmaceutical Sciences;Curitiba;;Brazil;15;91;6;34
146;8;moderate quality;Efficacy and safety of biologics in the treatment of moderate to severe psoriasis: A comprehensive meta-analysis of randomized controlled trials;597;Teles, Thaís De Souza;Universidade Federal do Parana;Curitiba;;Brazil;1;2;1;7
148;1;high quality;Plant extracts for the topical management of psoriasis: A systematic review and meta-analysis;143;Deng, Shiqiang;Royal Melbourne Institute of Technology University, School of Health Sciences;Melbourne;;Australia;7;52;5;5
148;2;high quality;Plant extracts for the topical management of psoriasis: A systematic review and meta-analysis;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;49;249;10;74
148;3;high quality;Plant extracts for the topical management of psoriasis: A systematic review and meta-analysis;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;176;2567;24;150
148;4;high quality;Plant extracts for the topical management of psoriasis: A systematic review and meta-analysis;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;95;947;16;150
148;5;high quality;Plant extracts for the topical management of psoriasis: A systematic review and meta-analysis;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;80;233;8;150
149;1;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;386;Martínez-Camblor, Pablo Martínez;Universidad Autónoma de Chile;Santiago de Chile;;Chile;112;1198;17;150
149;2;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;195;García-García, Begoña;Azienda Ospedaliera Santa Maria Nuova di Reggio Emilia, Skin Cancer Unit;Florence;;Italy;12;55;4;29
149;3;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;117;Coto-Segura, Pablo;Universidad de Oviedo, Department of Medicine;Oviedo;;Spain;66;336;10;136
149;4;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;118;Coto, Eliécer;Universidad de Oviedo, Department of Medicine;Oviedo;;Spain;297;7454;38;150
149;5;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;164;Eiris-Salvado, Noemí;Hospital Universitario Central de Asturias, Service of Dermatology;Oviedo;;Spain;3;22;1;17
149;6;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;208;Gómez-Bernal, Silvia;Hospital Universitario Central de Asturias, Service of Dermatology;Oviedo;;Spain;25;97;5;35
149;7;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;211;González-Lara, Leire;Hospital Universitario Central de Asturias, Department of Dermatology;Oviedo;;Spain;24;64;4;36
149;8;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;375;Maldonado-Seral, Cayetana;Hospital Universitario Central de Asturias, Service of Dermatology;Oviedo;;Spain;8;129;6;43
149;9;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;451;Palacios-García, Laura;Hospital Universitario Central de Asturias, Department of Dermatology;Oviedo;;Spain;6;43;3;17
149;10;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;492;Queiro, Ruben;Hospital Universitario Central de Asturias;Oviedo;;Spain;105;1062;20;150
149;11;high quality;Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: A systematic review and meta-analysis;528;Santos-Juanes, Jorge;Hospital Universitario Central de Asturias, Service of Anatomic Pathology;Oviedo;;Spain;110;593;13;150
150;1;high quality;Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.;433;Neilson, Julie M;Royal College of Physicians;London;;United Kingdom;10;118;4;42
150;2;high quality;Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.;458;Parnham, Jill;Royal College of Physicians;London;;United Kingdom;5;126;4;12
150;3;high quality;Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.;521;Samarasekera, Eleanor J.;Royal College of Physicians;London;;United Kingdom;7;125;5;14
150;4;high quality;Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.;561;Smith, Catherine H;Guy's and St Thomas' NHS Foundation Trust;London;;United Kingdom;127;4888;35;150
150;5;high quality;Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis.;650;Warren, R. B;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;98;1906;22;150
151;1;low quality;The efficacy of pulsed dye laser treatment for inflammatory skin diseases: A systematic review;136;De Jong, Elke M J G;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;5;67;3;8
151;2;low quality;The efficacy of pulsed dye laser treatment for inflammatory skin diseases: A systematic review;167;Erceg, Angelina;Amphia Hospital;Breda;;Netherlands;18;122;5;36
151;3;low quality;The efficacy of pulsed dye laser treatment for inflammatory skin diseases: A systematic review;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1190 ;19;150
151;4;low quality;The efficacy of pulsed dye laser treatment for inflammatory skin diseases: A systematic review;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;62;866 ;13;150
153;1;moderate quality;The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
153;2;moderate quality;The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1978;24;150
153;3;moderate quality;The association between psoriasis and hypertension: A systematic review and meta-analysis of observational studies;235;Harskamp, Caitlin T.;UC Davis, Department of Dermatology;Davis;;United States;20;539;9;18
154;1;high quality;Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis.;209;Gómez-Reino, Juan Jesús;Universidad de Santiago de Compostela, Facultad de Medicina, Department of Medicine;Santiago de Compostela;;Spain;309;14080;55;150
154;2;high quality;Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis.;382;Maneiro, José Ramón Amon;Instituto de Investigación Ramón Domínguez, Rheumatology Unit;Santiago de Compostela;;Spain;15;162;7;13
154;3;high quality;Immunogenicity of monoclonal antibodies against tumor necrosis factor used in chronic immune-mediated Inflammatory conditions: systematic review and meta-analysis.;520;Salgado, Eva;Universidad de Navarra, Department of Medicine;Pamplona;;Spain;18;180;8;15
155;1;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;50;255;10;75
155;2;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;177;2579;24;150
155;3;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;96;950;16;150
155;4;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;712;Zhang, Claireshuiqing;Royal Melbourne Institute of Technology University, School of Biomedical Sciences;Melbourne;;Australia;19;73;6;30
155;5;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;81;239;8;150
155;6;moderate quality;Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: A systematic review;705;Yu, Jasonjingjie;Guangdong Provincial Hospital of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences;Guangzhou;;China;5;13;2;11
156;1;high quality;Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis;23;Arends, Lidia R.;Erasmus University Medical Center, Department of Pulmonary Medicine;Rotterdam;;Netherlands;71;3079;27;150
156;2;high quality;Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis;158;Dowlatshahi, Emmilia Assal;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;11;211;7;29
156;3;high quality;Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis;436;Nijsten, Tamar E C;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;247;5705;37;150
156;4;high quality;Markers of systemic inflammation in psoriasis: A systematic review and meta-analysis;625;Van Der Voort, Ella A M;Amphia Hospital, Department of Dermatology, Breda;Breda;;Netherlands;12;180;4;35
157;1;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
157;2;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;29;Aubin, François J;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
157;3;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;750;18;150
157;4;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;61;Brénaut, Émilie;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;33;195;7;116
157;5;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
157;6;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;248;Horreau, C.;Hopital Nord AP-HM, Service of Dermatology;Marseille;;France;5;140;4;19
157;7;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
157;8;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
157;9;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
157;10;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
157;11;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
157;12;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275;39;150
157;13;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;480;Pouplard, C;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;6;153;5;36
157;14;low quality;Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;25;150
158;1;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
158;2;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
158;3;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;753;18;150
158;4;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;61;Brénaut, Émilie;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;33;195;7;116
158;5;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
158;6;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;248;Horreau, C.;Hopital Nord AP-HM, Service of Dermatology;Marseille;;France;5;140;4;19
158;7;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
158;8;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
158;9;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
158;10;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
158;11;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
158;12;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
158;13;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;480;Pouplard, C.;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;6;153;5;36
158;14;moderate quality;Risk of cancer in psoriasis: A systematic review and meta-analysis of epidemiological studies;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
159;1;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
159;2;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
159;3;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;753;18;150
159;4;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;61;Brénaut, Émilie;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;33;195;7;116
159;5;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
159;6;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;248;Horreau, C.;Hopital Nord AP-HM, Service of Dermatology;Marseille;;France;5;140;4;19
159;7;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
159;8;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
159;9;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
159;10;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
159;11;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
159;12;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
159;13;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;480;Pouplard, C.;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;6;153;5;36
159;14;moderate quality;Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: A systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
160;1;moderate quality;Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: A systematic literature review;136;De Jong, Elke M G J;Departments of Dermatology;Nijmegen;;Netherlands;200;3368;30;150
160;2;moderate quality;Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: A systematic literature review;241;Hendriks, Anke G M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;11;72;5;25
160;3;moderate quality;Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: A systematic literature review;282;Keijsers, Romy R M C;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;13;101;6;24
160;4;moderate quality;Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: A systematic literature review;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1192;19;150
160;5;moderate quality;Efficacy and safety of combinations of first-line topical treatments in chronic plaque psoriasis: A systematic literature review;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;62;869;13;150
161;1;high quality;Meta-analysis of the association between psoriasis and human leucocyte antigen-B;250;Hu, Li;Xi'an Jiaotong University, Department of Immunology and Pathogenic Biology; Xi'an;;China;12;81;6;11
161;2;high quality;Meta-analysis of the association between psoriasis and human leucocyte antigen-B;371;Ma, Junxian;Xi'an Jiaotong University, Department of Immunology and Pathogenic Biology; Xi'an;;China;9;39;4;14
161;3;high quality;Meta-analysis of the association between psoriasis and human leucocyte antigen-B;674;Xiao, Shengxiang;Xi'an Jiaotong University, Department of Dermatology; Xi'an;;China;62;186;6;149
161;4;high quality;Meta-analysis of the association between psoriasis and human leucocyte antigen-B;729;Zhao, Ya E.;Xi'an Jiaotong University, Department of Immunology and Pathogenic Biology; Xi'an;;China;23;244;11;32
161;5;high quality;Meta-analysis of the association between psoriasis and human leucocyte antigen-B;730;Zhao, Yaling;Kunming Medical University, Department of Obstetrics and Gynecology,;Kunming;;China;17;49;4;57
162;1;low quality;Alcohol consumption and psoriasis: a systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
162;2;low quality;Alcohol consumption and psoriasis: a systematic literature review;29;Aubin, François J;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
162;3;low quality;Alcohol consumption and psoriasis: a systematic literature review;48;Barnetche, Thomas;CHU Hopitaux de Bordeaux;Talence;;France;54;750;18;150
162;4;low quality;Alcohol consumption and psoriasis: a systematic literature review;61;Brénaut, Émilie;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;33;195;7;116
162;5;low quality;Alcohol consumption and psoriasis: a systematic literature review;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
162;6;low quality;Alcohol consumption and psoriasis: a systematic literature review;248;Horreau, C.;Hopital Nord AP-HM, Service of Dermatology;Marseille;;France;5;140;4;19
162;7;low quality;Alcohol consumption and psoriasis: a systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
162;8;low quality;Alcohol consumption and psoriasis: a systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
162;9;low quality;Alcohol consumption and psoriasis: a systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
162;10;low quality;Alcohol consumption and psoriasis: a systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
162;11;low quality;Alcohol consumption and psoriasis: a systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
162;12;low quality;Alcohol consumption and psoriasis: a systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275;39;150
162;13;low quality;Alcohol consumption and psoriasis: a systematic literature review;480;Pouplard, C;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;6;153;5;36
162;14;low quality;Alcohol consumption and psoriasis: a systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;25;150
165;1;low quality;Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis;170;Fan, Yiming;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;61;238;10;126
165;2;low quality;Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis;551;Shi, Ge;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;23;183;8;79
165;3;low quality;Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis;735;Zhu, Chengyao;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;18;198;7;106
165;4;low quality;Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis;736;Zhu, Kunju;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;36;1020;12;150
166;1;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;170;Fan, Yiming;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;61;241;10;126
166;2;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;329;Li, Mingchun;Shanghai Jiaotong University, Department of Hypertension;Shanghai;;China;7;37;5;35
166;3;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;551;Shi, Ge;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;23;183;8;79
166;4;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;711;Zhang, Chi;Fudan University, Department of Orthopaedics;Shanghai;;China;37;1497;13;150
166;5;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;735;Zhu, Chengyao;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;18;198;7;106
166;6;moderate quality;Leptin levels in patients with psoriasis: A meta-analysis;736;Zhu, Kunju;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;36;1022;12;150
167;1;moderate quality;Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk;46;Barišić-Druško, Vladimira;Private Dermatology Practice;Osije;;Croatia;20;156;6;46
167;2;moderate quality;Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk;512;Ručević, Ivana;Private Dermatology Practice;Osije;;Croatia;11;100;4;20
167;3;moderate quality;Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk;575;Štefanić, Mario;KBC Osijek, Department of Nuclear Medicine and Radiation Protection;Osije;;Croatia;15;34;4;41
168;1;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;170;Fan, Yiming;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;61;241;10;126
168;2;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;328;Li, Ming;Shanghai Jiaotong University, Department of Dermatology;Shanghai;;China;2;6;2;11
168;3;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;551;Shi, Ge;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;23;183;8;79
168;4;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;711;Zhang, Chi;Fudan University, Department of Orthopaedics;Shanghai;;China;37;1497;13;150
168;5;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;735;Zhu, Chengyao;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;18;198;7;106
168;6;moderate quality;Adiponectin levels in patients with psoriasis: A meta-analysis;736;Zhu, Kunju;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;36;1022;12;150
169;1;moderate quality;Transient Elastography for Detecting Liver Fibrosis in Methotrexate-Treated Patients with Inflammatory Disorders: A Systematic Review;48;Barra, Lillian J.;Western University, Division of Rheumatology;London;;Canada;22;292;8;110
169;2;moderate quality;Transient Elastography for Detecting Liver Fibrosis in Methotrexate-Treated Patients with Inflammatory Disorders: A Systematic Review;318;Levstik, Mark A.;London Health Sciences Centre;London;;Canada;26;2827;15;150
169;3;moderate quality;Transient Elastography for Detecting Liver Fibrosis in Methotrexate-Treated Patients with Inflammatory Disorders: A Systematic Review;;;;;;;;;;
169;4;moderate quality;Transient Elastography for Detecting Liver Fibrosis in Methotrexate-Treated Patients with Inflammatory Disorders: A Systematic Review;;;;;;;;;;
170;1;low quality;Etanercept provides an effective, safe and flexible short- and long- term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence;578;Strohal, Robert;Landeskrankenhaus Feldkirch, Department of Dermatology and Venereology;Feldkirch;;Austria;62;960;17;150
170;2;low quality;Etanercept provides an effective, safe and flexible short- and long- term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence;105;Chimenti, Sergio;Universita degli Studi di Roma Tor Vergata, Department of Dermatology;Rome;;Italy;495;12100;46;150
170;3;low quality;Etanercept provides an effective, safe and flexible short- and long- term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence;204;Girolomoni, G;Universita degli Studi di Verona, Department of Medicine;Verona;;Italy;398;12836;62;150
170;4;low quality;Etanercept provides an effective, safe and flexible short- and long- term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence;631;Vena, Gino Antonio Ntonio;Private Practitioner;Bari;;Italy;322;3933;27;150
171;1;moderate quality;Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses;521;Samarasekera, Eleanor J.;Royal College of Physicians;London;;United Kingdom;7;126;5;14
171;2;moderate quality;Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses;529;Sawyer, Laura J.;Symmetron Limited, Kinetic Centre;London;yes;United Kingdom;16;155;7;36
171;3;moderate quality;Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses;561;Smith, Catherine H.;Guy's and St Thomas' NHS Foundation Trust;London;;United Kingdom;127;4901;35;150
171;4;moderate quality;Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses;615;Tucker, Rod P.;Robert Gordon University, School of Pharmacy and Life Sciences;Aberdeen;;United Kingdom;35;118;4;33
171;5;moderate quality;Topical therapies for the treatment of plaque psoriasis: Systematic review and network meta-analyses;661;Wonderling, David E.;National Clinical Guideline Centre;London;;United Kingdom;42;1758;18;150
173;1;high quality;Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: A meta-analysis of randomized controlled trials;739;Zoubaulis, Christos C;European Hidradenitis Suppurativa Foundation e.V.;Dessau-Rosslau;;Germany;573;13107;64;150
173;2;high quality;Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: A meta-analysis of randomized controlled trials;300;Kyrgidis, Athanassios;Aristotle University of Thessaloniki, Department of Oral and Maxillofacial Surgery;Thessaloniki;;Greece;99;1017;17;150
173;3;high quality;Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: A meta-analysis of randomized controlled trials;616;Tzellos, Thrasivoulos George;University Hospital of North Norway, Department of Dermatology;Tromso;;Norway;70;931;19;150
175;1;high quality;Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;181;2340;31;150
175;2;high quality;Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1967;24;150
175;3;high quality;Psoriasis and metabolic syndrome: A systematic review and meta-analysis of observational studies;235;Harskamp, Caitlin T.;University of Southern California;Los Angeles;;United States;20;534;9;18
176;1;moderate quality;Topical herbal medicine combined with pharmacotherapy for psoriasis: A systematic review and meta-analysis;143;Deng, Shiqiang;Royal Melbourne Institute of Technology University, School of Health Sciences;Melbourne;;Australia;7;52;5;5
176;2;moderate quality;Topical herbal medicine combined with pharmacotherapy for psoriasis: A systematic review and meta-analysis;394;May, Brian H.;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;50;255;10;75
176;3;moderate quality;Topical herbal medicine combined with pharmacotherapy for psoriasis: A systematic review and meta-analysis;679;Xue, Charlie C L;Royal Melbourne Institute of Technology University;Melbourne;;Australia;177;2579;24;150
176;4;moderate quality;Topical herbal medicine combined with pharmacotherapy for psoriasis: A systematic review and meta-analysis;709;Zhang, Anthonylin;Royal Melbourne Institute of Technology University, China-Australia International Research Centre for Chinese Medicine;Melbourne;;Australia;96;950;16;150
176;5;moderate quality;Topical herbal medicine combined with pharmacotherapy for psoriasis: A systematic review and meta-analysis;361;Lu, Chuanjian;Guangzhou University, Second School of Clinic Medicine;Guangzhou;;China;81;239;8;150
177;1;moderate quality;Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
177;2;moderate quality;Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1978;24;150
177;3;moderate quality;Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.;235;Harskamp, Caitlin T.;UC Davis, Department of Dermatology;Davis;;United States;20;539;9;18
178;1;moderate quality;Systematic review of UV-based therapy for psoriasis;648;Wang, Yun;Shandong University, Department of Neurology;Jinan;;China;27;43;11;85
178;2;moderate quality;Systematic review of UV-based therapy for psoriasis;13;Almutawa, Fahad;Health Sciences Center Kuwait Faculty of Medicine, Department of Medicine;Safat;;Kuwait;8;94;5;18
178;3;moderate quality;Systematic review of UV-based therapy for psoriasis;14;Alnomair, Naif;Icahn School of Medicine at Mount Sinai, Department of Dermatology;New York;;United States;1;23;1;4
178;4;moderate quality;Systematic review of UV-based therapy for psoriasis;229;Hamzavi, Iltefat H.;Henry Ford Hospital, Department of Dermatology;Detroit;;United States;80;1385;23;150
178;5;moderate quality;Systematic review of UV-based therapy for psoriasis;344;Lim, Henry;Henry Ford Hospital, Department of Dermatology;Detroit;;United States;296;6734;39;150
179;1;low quality;Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review;136;De Jong, Elke M G J;Departments of Dermatology;Nijmegen;;Netherlands;200;3361;30;150
179;2;low quality;Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review;241;Hendriks, Anke G M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;11;72;5;25
179;3;low quality;Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review;282;Keijsers, Romy R M C;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;13;101;6;24
179;4;low quality;Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1190;19;150
179;5;low quality;Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;62;866;13;150
180;1;low quality;Cost Effectiveness of Biologic Therapies for Plaque Psoriasis;7;Ahn, Christine;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;12;49;3;19
180;2;low quality;Cost Effectiveness of Biologic Therapies for Plaque Psoriasis;133;Davis, Scott A;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;80;355;9;103
180;3;low quality;Cost Effectiveness of Biologic Therapies for Plaque Psoriasis;175;Feldman, Steven R;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;812;16583;59;150
180;4;low quality;Cost Effectiveness of Biologic Therapies for Plaque Psoriasis;226;Gustafson, Cheryl J.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;29;120;6;58
180;5;low quality;Cost Effectiveness of Biologic Therapies for Plaque Psoriasis;525;Sandoval, Laura F.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;32;101;5;39
181;1;moderate quality;The association between psoriasis and dyslipidaemia: A systematic review;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
181;2;moderate quality;The association between psoriasis and dyslipidaemia: A systematic review;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1978;24;150
181;3;moderate quality;The association between psoriasis and dyslipidaemia: A systematic review;235;Harskamp, Caitlin T.;UC Davis, Department of Dermatology;Davis;;United States;20;539;9;18
181;4;moderate quality;The association between psoriasis and dyslipidaemia: A systematic review;370;Ma, Chelsea;UC Davis, Department of Dermatology;Davis;;United States;4;62;4;6
182;1;low quality;Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence;27;Ashcroft, Darren M.;Manchester Academic Health Sciences Centre, NIHR Greater Manchester Patient Safety Translational Research Centre;Manchester;;United Kingdom;163;3314;29;150
182;2;low quality;Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25840 ;85;150
182;3;low quality;Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence;456;Parisi, Rosa;University of Manchester, Centre for Pharmacoepidemiology and Drug Safety;Manchester;;United Kingdom;3;342;3;11
182;4;low quality;Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence;587;Symmons, Deborah P. M;University of Manchester,;Manchester;;United Kingdom;347;23938;75;150
185;1;moderate quality;Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
185;2;moderate quality;Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis;25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1978;24;150
185;3;moderate quality;Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis;235;Harskamp, Caitlin T.;UC Davis, Department of Dermatology;Davis;;United States;20;539;9;18
186;1;moderate quality;Apolipoprotein E Gene Polymorphism in Psoriasis: A Meta-analysis;230;Han, Yi;Kunming Medical University, School of Basic Medical Sciences;Kunming;;China;5;44;3;21
186;2;moderate quality;Apolipoprotein E Gene Polymorphism in Psoriasis: A Meta-analysis;352;Liu, Tong;Kunming Medical University, Department of Physiology;Kunming;;China;2;13;2;2
186;3;moderate quality;Apolipoprotein E Gene Polymorphism in Psoriasis: A Meta-analysis;362;Lu, Lechun;Kunming Medical University, Department of Physiology;Kunming;;China;10;31;4;27
187;1;low quality;Biological treatments for moderate-to-severe psoriasis: indirect comparison;48;Bautista Paloma, Francisco Javier;Hospital Universitario Virgen del Rocio, Unidad de Gestión Clínica de Farmacia;Sevilla;;Spain;14;44;4;32
187;2;low quality;Biological treatments for moderate-to-severe psoriasis: indirect comparison;190;Galván-Banqueri, Mercedes;Andalusian Agency for Health Technology Assessment;Sevilla;;Spain;17;67;5;29
187;3;low quality;Biological treatments for moderate-to-severe psoriasis: indirect comparison;384;Marín Gil, Roberto;Hospital Universitario Virgen del Rocio, Unidad de Gestión Clínica de Farmacia;Sevilla;;Spain;11;51;3;37
187;4;low quality;Biological treatments for moderate-to-severe psoriasis: indirect comparison;527;Santos Ramos, Bernardo;Unidad de Gestión Clínica de Genética;Sevilla;;Spain;56;202;8;114
188;1;moderate quality;Adherence to medication in patients with psoriasis: A systematic literature review;27;Ashcroft, Darren M.;Manchester Academic Health Sciences Centre, NIHR Greater Manchester Patient Safety Translational Research Centre;Manchester;;United Kingdom;163;3322;29;150
188;2;moderate quality;Adherence to medication in patients with psoriasis: A systematic literature review;70;Bundy, Christine E.;University of Manchester, Greater Manchester Collaboration for Leadership in Applied Health Research and Care;Manchester;;United Kingdom;76;1269;18;150
188;3;moderate quality;Adherence to medication in patients with psoriasis: A systematic literature review;113;Cordingley, Lis;University of Manchester, School of Medicine;Manchester;;United Kingdom;49;714;13;123
188;4;moderate quality;Adherence to medication in patients with psoriasis: A systematic literature review;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25879;85;150
188;5;moderate quality;Adherence to medication in patients with psoriasis: A systematic literature review;608;Thorneloe, Rachael J.;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;1;35;1;4
189;1;moderate quality;Quantifying cardiovascular disease risk factors in patients with psoriasis: A meta-analysis;166;Ellervik, Christina;Nykobing F. Sygehus, Department of Research;Nykobing Falster;;Denmark;61;904;16;120
189;2;moderate quality;Quantifying cardiovascular disease risk factors in patients with psoriasis: A meta-analysis;263;Jemec, Gregor B.E.;Kobenhavns Universitet, Department of Dermatology;Copenhagen;;Denmark;439;7871;48;150
189;3;moderate quality;Quantifying cardiovascular disease risk factors in patients with psoriasis: A meta-analysis;410;Miller, Iben Marie;Faculty of Health and Medical Sciences;Copenhagen;;Denmark;30;263;8;47
189;4;moderate quality;Quantifying cardiovascular disease risk factors in patients with psoriasis: A meta-analysis;560;Skaaby, Tea;Research Centre for Prevention and Health;Copenhagen;;Denmark;55;450;11;150
190;1;high quality;Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.;99;Chen, Xiaomei;Chinese Academy of Medical Sciences, Institute of Medicinal Plant Development;Beijing;;China;9;21;2;26
190;2;high quality;Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.;103;Cheng, Yan;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;1;11;1;4
190;3;high quality;Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.;349;Liu, Guan J.;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;1;11;1;4
190;4;high quality;Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.;692;Yang, Ming;Sichuan University ;Chengdu;;China;20;78;5;32
190;5;high quality;Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis.;720;Zhang, Min;Sichuan University, Department of Dermatology and Venereology;Chengdu;;China;1;11;1;4
191;1;high quality;Thiazolidinediones for plaque psoriasis: A systematic review and meta-analysis;152;Dogra, Sunil;Postgraduate Institute of Medical Education and Research, Department of Pharmacology;Chandigarh;;India;100;592;13;150
191;2;high quality;Thiazolidinediones for plaque psoriasis: A systematic review and meta-analysis;376;Malhotra, Anita S.;Government Medical College & Hospital Chandigarh, Department of Physiology;Chandigarh;;India;7;51;4;31
191;3;high quality;Thiazolidinediones for plaque psoriasis: A systematic review and meta-analysis;377;Malhotra, Samir L.;Postgraduate Institute of Medical Education and Research, Department of Pharmacology;Chandigarh;;India;151;1813;23;150
191;4;high quality;Thiazolidinediones for plaque psoriasis: A systematic review and meta-analysis;493;Rajagopalan, Sujit;Postgraduate Institute of Medical Education and Research, Department of Pharmacology;Chandigarh;;India;8;47;3;19
191;5;high quality;Thiazolidinediones for plaque psoriasis: A systematic review and meta-analysis;540;Shafiq, Nusrat;Postgraduate Institute of Medical Education and Research, Department of Pharmacology;Chandigarh;;India;61;801;13;150
192;1;high quality;"The association between psoriasis and obesity: a systematic
review and meta-analysis of observational studies";24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;181;2340;31;150
192;2;high quality;"The association between psoriasis and obesity: a systematic
review and meta-analysis of observational studies";25;Armstrong, Ehrin J.;University of Colorado School of Medicine, Division of Cardiology and VA Eastern Colorado Healthcare System;Denver;;United States;142;1967;24;150
192;3;high quality;"The association between psoriasis and obesity: a systematic
review and meta-analysis of observational studies";235;Harskamp, Caitlin T.;University of Southern California;Los Angeles;;United States;20;534;9;18
193;1;moderate quality;Association of psoriasis with stroke and myocardial infarction: Meta-analysis of cohort studies;677;Xu, Tian;Soochow University, Department of Epidemiology;Suzhou;;China;25;182;6;95
193;2;moderate quality;Association of psoriasis with stroke and myocardial infarction: Meta-analysis of cohort studies;726;Zhang, Yuhua;Soochow University, Department of Epidemiology;Suzhou;;China;484;5574;39;150
194;1;high quality;Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.;146;Devine, Emily Beth Eth;University of Washington, Department of Pharmacy;Seattle;;United States;62;1183;17;150
194;2;high quality;Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.;347;Lin, Vincent W.;University of Washington Seattle, School of Pharmacy;Seattle;;United States;4;60;2;10
194;3;high quality;Comparison of Ustekinumab With Other Biological Agents for the Treatment of Moderate to Severe Plaque Psoriasis: A Bayesian Network Meta-analysis.;503;Ringold, Sarah;Children's Hospital and Regional Medical Center;Seattle;;United States;72;1246;18;150
195;1;low quality;Sexual dysfunction in patients with psoriasis and psoriatic arthritis − a systematic review;128;Da Mota, Licia Maria Henrique;Universidade de Brasilia;Brasilia;;Brazil;69;471;12;150
195;2;low quality;Sexual dysfunction in patients with psoriasis and psoriatic arthritis − a systematic review;297;Kurizky, Patricia Shu;Dermatology Service at Hospital Universitário de Brasília (HUB, Hospital das Forças Armadas);Brasilia;;Brazil;5;14;2;12
196;1;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;34;Bachmann, Frank F.;Division of Nephrology, Department of Internal Medicine;Berlin;;Germany;74;516;11;126
196;2;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;168;Erdmann, Ricardo;Charite - Universitatsmedizin Berlin, Division of Evidence Based Medicine (dEBM);Berlin;;Germany;37;1033;16;150
196;3;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;363;Lucka, T. C.;Charite - Universitatsmedizin Berlin, Division of Evidence Based Medicine (dEBM);Berlin;;Germany;2;29;1;9
196;4;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;430;Nast, Alexander;Charite - Universitatsmedizin Berlin;Berlin;;Germany;116;2126;22;150
196;5;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;445;Orawa, Helmut;Wissenschaftsdienste;Berlin;;Germany;24;775;12;121
196;6;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;463;Pathirana, Delano;Klinik für Dermatologie, Venerologie und Allergologie, Division of Evidence Based Medicine (DEBM);Berlin;;Germany;16;561;9;97
196;7;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;508;Rosumeck, Stefanie;Charite - Universitatsmedizin Berlin, Department of Dermatology;Berlin;;Germany;37;697;11;112
196;8;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;518;Rzany, Berthold J.;RZANY and HUND;Berlin;;Germany;236;6391;38;150
196;9;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;523;Sammain, Adel;Klinik für Dermatologie, Venerologie und Allergologie, Division of Evidence Based Medicine (DEBM);Berlin;;Germany;13;419;9;63
196;10;moderate quality;Efficacy of systemic therapies for moderate-to-severe psoriasis: A systematic review and meta-analysis of long-term treatment;531;Schmitt, Jochen M.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;167;3323;33;150
197;1;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;303;Lamel, Sonia A.;Metropolitan Hospital Center, Department of Dermatology;New York;;United States;20;130;7;38
197;2;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;373;Maibach, Hilda J.;Social & Scientific Systems, Inc.;Silver Spring;yes;United States;3;82;3;10
197;3;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;374;Maibach, Howard Ira;University of California System;Oakland;;United States;1475;32327;79;150
197;4;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;424;Myer, Kaley A.;University of California, San Francisco, Department of Dermatology;San Francisco;;United States;4;20;2;12
197;5;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;703;Younes, Naji;George Washington University, Biostatistics Center;Washington;;United States;25;1912;15;150
197;6;moderate quality;Placebo response in relation to clinical trial design: A systematic review and meta-analysis of randomized controlled trials for determining biologic efficacy in psoriasis treatment;732;Zhou, James A.;Social & Scientific Systems, Inc.;Silver Spring;yes;United States;1;9;1;5
199;1;moderate quality; systematic review of systemic medications for pustular psoriasis in pediatrics ;308;Lara-Corrales, Irene;Hospital for Sick Children University of Toronto, Division of Paediatric Medicine;Toronto;;Canada;40;385;10;125
199;2;moderate quality; systematic review of systemic medications for pustular psoriasis in pediatrics ;476;Pope, Elena;Hospital for Sick Children University of Toronto, Department of Pediatrics;Toronto;;Canada;109;1920;22;150
199;3;moderate quality; systematic review of systemic medications for pustular psoriasis in pediatrics ;478;Posso-De Los Rios, Claudia J.;Hospital for Sick Children University of Toronto, Division of Paediatric Medicine;Toronto;;Canada;6;19;3;8
202;1;low quality;Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review;355;Loerbroks, Adrian;Universitatsklinikum Mannheim, Mannheim Institute of Public Health, Social and Preventive Medicine;Mannheim;;Germany;77;820;17;150
202;2;low quality;Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review;600;Terris, Darcey D;Universitat Heidelberg, Mannheim Institute of Public Health, Social and Preventive Medicine;Heidelberg;;Germany;29;275 ;11;62
202;3;low quality;Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review;617;Umar, Nasir;Universitatsklinikum Mannheim;Mannheim;;Germany;9;108;6;11
202;4;low quality;Elicitation and Use of Patients’ Preferences in the Treatment of Psoriasis: A Systematic Review;680;Yamamoto, Shelby;Universitatsklinikum Mannheim, Mannheim Institute of Public Health, Social and Preventive Medicine;Mannheim;;Germany;1;10;1;3
204;1;low quality;Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;181;2341;31;150
204;2;low quality;Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy;62;Brezinski, Elizabeth A;Harvard Combined Dermatology Residency Training Program;Boston;;United States;14;154;7;22
205;1;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
205;2;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
205;3;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;29;Aubin, François J;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
205;4;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4248 ;36;150
205;5;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;85;Castela, A.;Universite Nice Sophia Antipolis, Department of Dermatology;Nice;;France;2;72;2;14
205;6;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
205;7;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
205;8;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;511;14;86
205;9;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
205;10;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
205;11;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
205;12;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
205;13;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
205;14;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
205;15;low quality;Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;28;150
206;1;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
206;2;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
206;3;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
206;4;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
206;5;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;261;8;56
206;6;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
206;7;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
206;8;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
206;9;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
206;10;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
206;11;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
206;12;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
206;13;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
206;14;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
206;15;moderate quality;Efficacy of Psoralen UV-A therapy vs. Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
207;1;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
207;2;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
207;3;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
207;4;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
207;5;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;261;8;56
207;6;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
207;7;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
207;8;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
207;9;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
207;10;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
207;11;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
207;12;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
207;13;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
207;14;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
207;15;moderate quality;Evidence-based recommendations on topical treatment and phototherapy of psoriasis: Systematic review and expert opinion of a panel of dermatologists;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
208;1;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
208;2;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
208;3;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
208;4;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4248 ;36;150
208;5;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;215;8;56
208;6;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
208;7;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
208;8;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;511;14;86
208;9;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
208;10;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
208;11;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
208;12;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
208;13;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
208;14;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
208;15;low quality;Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;28;150
209;1;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
209;2;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
209;3;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
209;4;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
209;5;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;261;8;56
209;6;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
209;7;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
209;8;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
209;9;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
209;10;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
209;11;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
209;12;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
209;13;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
209;14;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
209;15;moderate quality;Topical corticosteroids in plaque psoriasis: A systematic review of efficacy and treatment modalities;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
210;1;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
210;2;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
210;3;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
210;4;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
210;5;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;261;8;56
210;6;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
210;7;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
210;8;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
210;9;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
210;10;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
210;11;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
210;12;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
210;13;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
210;14;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
210;15;moderate quality;Carcinogenic risks of Psoralen UV-A therapy and Narrowband UV-B therapy in chronic plaque psoriasis: A systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
211;1;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
211;2;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
211;3;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
211;4;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4248 ;36;150
211;5;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;215;8;56
211;6;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
211;7;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
211;8;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;511;14;86
211;9;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
211;10;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
211;11;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
211;12;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
211;13;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
211;14;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
211;15;low quality;Adherence to topical treatment in psoriasis: a systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;28;150
213;1;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
213;2;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;21;Archier, Elodie;Aix Marseille Universite, Dermatology and Skin Cancers Department;Marseille;;France;11;251;8;28
213;3;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
213;4;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4248 ;36;150
213;5;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;86;Castela, Emeline;CHU de Nice, Department of Dermatology;Nice;;France;15;215;8;56
213;6;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
213;7;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;145;Devaux, Suzanne;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;11;234;8;25
213;8;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;511;14;86
213;9;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
213;10;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
213;11;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
213;12;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
213;13;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
213;14;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
213;15;low quality;Ocular damage in patients with psoriasis treated by Psoralen UV-A therapy or Narrow band UVB therapy: a systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;28;150
214;1;moderate quality;Combination treatments for psoriasis: A systematic review and meta-analysis;39;Bailey, Elizabeth E.;London School of Economics and Political Science, Department of Social Policy;London;;United Kingdom;6;129;5;20
214;2;moderate quality;Combination treatments for psoriasis: A systematic review and meta-analysis;10;Alikhan, Ali;University of Cincinnati, Department of Dermatology;Cincinnati;;United States;74;866;14;126
214;3;moderate quality;Combination treatments for psoriasis: A systematic review and meta-analysis;24;Armstrong, April Wang;University of Southern California;Los Angeles;;United States;188;2367;31;150
214;4;moderate quality;Combination treatments for psoriasis: A systematic review and meta-analysis;176;Ference, Elisabeth H.;Northwestern University Feinberg School of Medicine, Department of Otolaryngology-Head and Neck Surgery;Chicago;;United States;13;73;4;42
214;5;moderate quality;Combination treatments for psoriasis: A systematic review and meta-analysis;244;Hession, Meghan T.;Boston Medical Center, Department of Dermatology;Boston;;United States;12;68;5;26
215;1;moderate quality;Efficacy of externally applied chinese herbal drugs in treating psoriasis: A systematic review ;38;Bai, Yanping;China-Japan Friendship Hospital, Department of Dermatology and Venereology;Beijing;;China;15;58;5;60
215;2;moderate quality;Efficacy of externally applied chinese herbal drugs in treating psoriasis: A systematic review ;220;Guo, Wei;Xi’an Janssen Pharmaceutical Ltd., Beijing; Xi'an;yes;China;1;9;1;4
215;3;moderate quality;Efficacy of externally applied chinese herbal drugs in treating psoriasis: A systematic review ;324;Li, Hongyan;Nanjing University, State Key Laboratory of Food Science and Technology;Nanjing;;China;570;6679;42;150
215;4;moderate quality;Efficacy of externally applied chinese herbal drugs in treating psoriasis: A systematic review ;330;Li, Nuo;China-Japan Friendship Hospital, Department of Dermatology and Venereology;Beijing;;China;5;13;2;18
215;5;moderate quality;Efficacy of externally applied chinese herbal drugs in treating psoriasis: A systematic review ;340;Li, YueQing;Beijing University of Chinese Medicine;Beijing;;China;2;11;2;10
216;1;low quality;Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis;286;Kimball, Alexa Boer Oer;Massachusetts General Hospital, Department of Dermatology;Boston;;United States;223;6284;39;150
216;2;low quality;Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis;505;Robinson, Amanda E;University of Massachusetts Medical School, Department of Medicine;Worcester;;United States;7;182;4;27
216;3;low quality;Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis;278;Kardos, Marisa;CURTIS, Boston,;Corvallis;;United States;6;110;3;22
217;1;moderate quality;Efficacy of biologics in the treatment of moderate to severe psoriasis: A network meta-analysis of randomized controlled trials;497;Reich, Kristian;Dermatologikum Hamburg;Hamburg;;Germany;242;9384;53;150
217;2;moderate quality;Efficacy of biologics in the treatment of moderate to severe psoriasis: A network meta-analysis of randomized controlled trials;72;Burden, Arthur David;University of Glasgow, Department of Dermatology;Glasgow;;United Kingdom;99;4267;32;150
217;3;moderate quality;Efficacy of biologics in the treatment of moderate to severe psoriasis: A network meta-analysis of randomized controlled trials;163;Eaton, James N.;ICON Health Economics & Epidemiology;Abingdon;yes;United Kingdom;9;204;5;38
217;4;moderate quality;Efficacy of biologics in the treatment of moderate to severe psoriasis: A network meta-analysis of randomized controlled trials;237;Hawkins, Neil Stephen;ICON Clinical Research (UK) Ltd.,;Abingdon;yes;United Kingdom;58;1904;20;150
221;1;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;97;Chen, Wanqiang;Lanzhou University, Institute of Integrated Traditional Chinese and Western Medicine;Lanzhou;;China;1;4;1;6
221;2;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;332;Li, Shaohong;Lanzhou University, Institute of Immunology;Lanzhou;;China;3;5;1;7
221;3;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;368;Ma, Bin;Lanzhou University, First Clinical Medical College;Lanzhou;;China;105;449;13;150
221;4;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;588;Tan, Jiying;Lanzhou University, Evidence-Based Medicine Center;Lanzhou;;China;24;51;4;59
221;5;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;689;Yang, Kehu;Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province;Lanzhou;;China;319;1217;19;150
221;6;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;707;Zha, ChengXi;Lanzhou University, Institute of Biochemistry and Molecular Biology;Lanzhou;;China;4;4;1;14
221;7;moderate quality;Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: A meta-analysis;718;Zhang, Junying;Beijing Normal University, BABRI Centre;Beijing;;China;21;136;7;57
224;1;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;93;Chen, Hongduo;Hospital of China Medical University, Department of Dermatology, Qingshuihe;Shenzhen;;China;210;1946;20;150
224;2;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;193;Gao, Xinghua;Hospital of China Medical University, Department of Dermatology, Qingshuihe;Shenzhen;;China;143;1078;17;150
224;3;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;339;Li, Yuanhong;Hospital of China Medical University, Department of Dermatology, Qingshuihe;Shenzhen;;China;45;479;13;150
224;4;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;351;Liu, Jun;China Medical University Shenyang, Department of Oncology;Shenyang;;China;172;3313;30;150
224;5;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;638;Wang, Bin;Hospital of China Medical University, Department of Dermatology, Qingshuihe;Shenzhen;;China;8;31;3;20
224;6;moderate quality;Association of -619C/T polymorphism in CDSN gene and psoriasis risk: A meta-analysis;669;Wu., Yan;Shanghai Jiaotong University, School of Nuclear Science and Engineering;Shanghai;;China;1315;16592;57;150
225;1;moderate quality;Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review ;305;Langham, Julia;London School of Hygiene & Tropical Medicine, Department of Medical Statistics;London;;United Kingdom;17;154;6;46
225;2;moderate quality;Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review ;306;Langham, Sue;PHMR consulting;London;yes;United Kingdom;8;189;7;18
225;3;moderate quality;Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review ;206;Goertz, Hans Peter;Genentech Incorporated;San Francisco;yes;United States;4;27;1;17
225;4;moderate quality;Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review ;495;Ratcliffe, Mark B;VA Medical Center, Department of Surgery;;;United States;118;2997;30;150
229;1;moderate quality;Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature;174;Federman, Daniel Glenn Lenn;VA Medical Center;;;United States;159;2557;25;150
229;2;moderate quality;Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature;289;Kirsner, Robert Scott F;University of Miami Leonard M. Miller School of Medicine, Department of Dermatology and Cutaneous Surgery;Miami;;United States;518;9369;47;150
229;3;moderate quality;Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature;462;Patel, Rita V.;Icahn School of Medicine at Mount Sinai, Department of Dermatology;New York;;United States;20;257;7;20
229;4;moderate quality;Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature;483;Prodanovich, Srdjan;University of Miami, Department of Dermatology and Cutaneous Surgery;Coral Gables;;United States;12;362;7;28
229;5;moderate quality;Psoriasis and vascular disease-risk factors and outcomes: A systematic review of the literature;543;Shelling, Michael L.;University of Miami Leonard M. Miller School of Medicine, Department of Dermatology, Miami;Miami;;United States;18;149;6;20
230;1;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;307;Langley, Richard G B;Dalhousie University;Halifax;;Canada;145;8699;46;150
230;2;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;55;Blankenship, Derek;Baylor University Medical Center at Dallas, Department of Research and Improvement Education;Dallas;;United States;1;128;1;13
230;3;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;131;Daoud, Yahya A;Baylor Research Institute, Department of Dermatology;Dallas;;United States;9;305;6;49
230;4;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;137;De Lemos, James A.;UT Southwestern Medical School, Department of Internal Medicine;Dallas;;United States;391;22037;68;150
230;5;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;186;Friedewald, Vincent E;American Journal of Cardiology;;;United States;63;732;11;139
230;6;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;213;Gordon, Kenneth B;Northwestern University Feinberg School of Medicine, Department of Dermatology;Chicago;;United States;127;9281;48;150
230;7;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;277;Kaplan, Daniel H.;University of Pittsburgh, Department of Immunology;Pittsburgh;;United States;60;5521;26;150
230;8;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;280;Kazi, Salahuddin;UT Southwestern Medical Center, Rheumatic Diseases Division;Dallas;;United States;17;676;11;67
230;9;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;286;Kimball, Alexa Boer Oer;Massachusetts General Hospital, Department of Dermatology;Boston;;United States;223;6282;39;150
230;10;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;296;Krueger, James G.;Rockefeller University, Laboratory for Investigative Dermatology;New York;;United States;270;20048;79;150
230;11;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;315;Leonardi, Craig L.;St. Louis University School of Medicine, Department of Dermatology;St Louis;;United States;126;8590;41;150
230;12;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;405;Menter, Alan M;Baylor University Medical Center at Dallas, Department of Dermatology;Dallas;;United States;278;15295;59;150
230;13;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;515;Ryan, Caitriona;Texas A and M Health Science Center, Department of Medical Education, College Station;Texas;;United States;32;849;14;97
230;14;high quality;Association Between Biologic Therapies for Chronic Plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials;577;Strober, Bruce E.;University of Connecticut School of Medicine, Department of Dermatology;Farmington;;United States;119;3856;31;150
231;1;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;3;Abuabara, Katrina Elaine;University of California, San Francisco, Department of Dermatology;San Francisco;;United States;37;1073;13;150
231;2;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;153;Dommasch, Erica D;Harvard Medical School, Department of Dermatology, ;Boston;;United States;10;411;7;28
231;3;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;200;Gelfand, Joel M;University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics;Philadelphia;;United States;160;8231;43;150
231;4;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;434;Nguyen, Josephine C;University of Pennsylvania, Department of Dermatology;Philadelphia;;United States;16;370;9;49
231;5;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;553;Shin, Daniel;University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics;Philadelphia;;United States;44;3721;26;128
231;6;high quality;The Risk of Infection and Malignancy with Tumor Necrosis Factor Antagonists in Adult Patients with Psoriatic Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials;614;Troxel, Andrea B;University of Pennsylvania, Department of Biostatistics and Epidemiology;Philadelphia;;United States;191;10439;49;150
232;1;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
232;2;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
232;3;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
232;4;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
232;5;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
232;6;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
232;7;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
232;8;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
232;9;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;397;Maza, Aude;CHU de Toulouse, Department of Dermatology;Nice;;France;26;270;8;109
232;10;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
232;11;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;416;Montaudié, Henri;CHU de Nice, Department of Dermatology;Nice;;France;25;246;6;81
232;12;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
232;13;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
232;14;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
232;15;moderate quality;Oral cyclosporin in psoriasis: A systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis;530;Sbidian, Émilie;Universite Paris-Est;Marne-la-Vallee;;France;57;383;10;150
233;1;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4585;39;150
233;2;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;3153;39;150
233;3;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
233;4;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;122;Cribier, Bernard J.;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;392;6415;42;150
233;5;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512;14;86
233;6;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;403;8217;48;150
233;7;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3684;36;150
233;8;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
233;9;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;397;Maza, Aude;CHU de Toulouse, Department of Dermatology;Toulouse;;France;26;270;8;109
233;10;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4258;36;150
233;11;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;416;Montaudié, Henri;CHU de Nice, Department of Dermatology;Nice;;France;25;246;6;81
233;12;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4461;36;150
233;13;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
233;14;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2558;29;150
233;15;moderate quality;Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review;530;Sbidian, Émilie;Universite Paris-Est;Marne-la-Vallee;;France;57;383;10;150
235;1;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
235;2;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
235;3;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;33;Bachelez, Hervé;Universite Paris 7- Denis Diderot;Paris;;France;178;4254;36;150
235;4;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
235;5;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;189;Gallini, Adeline;CHU de Toulouse, Faculty of Medicine;Toulouse;;France;35;512 ;14;86
235;6;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
235;7;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
235;8;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
235;9;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;397;Maza, Aude;CHU de Toulouse, Department of Dermatology;Toulouse;;France;26;270;8;109
235;10;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;413;Misery, Laurent;Centre Hospitalier Universitaire de Brest, Department of Dermatology;Brest;;France;394;4253;36;150
235;11;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;416;Montaudié, Henri;CHU de Nice, Department of Dermatology;Nice;;France;25;246;6;81
235;12;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
235;13;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
235;14;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;500;Richard, Marie Aleth;Hopital La Timone;Marseille;;France;163;2554;25;150
235;15;moderate quality;Methotrexate in psoriasis: A systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicit;530;Sbidian, Émilie;Universite Paris-Est;Marne-la-Vallee;;France;57;383;10;150
238;1;low quality;Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease;134;De Hullu, Joanne A;Radboud University Medical Center, Department of Obstetrics and Gynecology;Nijmegen;;Netherlands;117;2743;29;150
238;2;low quality;Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease;391;Massuger, Leon Fag A G;Radboud University Medical Center, Department of Obstetrics and Gynecology;Nijmegen;;Netherlands;358;6788;43;150
238;3;low quality;Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease;402;Meeuwis, Kim A P;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;15;170;8;28
238;4;low quality;Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;657;13886;52;150
238;5;low quality;Genital Psoriasis: A Systematic Literature Review on this Hidden Skin Disease;628;Van Rossum, Michelle M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;72;1259;19;150
240;1;moderate quality;The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderatelysevere scalp psoriasis: A systematic review of direct and indirect evidence;517;Ryttov, Jacob;LEO Pharma AS;Ballerup;yes;Denmark;4;37;4;10
240;2;moderate quality;The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderatelysevere scalp psoriasis: A systematic review of direct and indirect evidence;58;Bottomley, Julia M.;Amygdala Ltd.;Letchworth;yes;United Kingdom;18;184;9;43
240;3;moderate quality;The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderatelysevere scalp psoriasis: A systematic review of direct and indirect evidence;593;Taylor, R. S.;University of Exeter;Exeter;;United Kingdom;150;4677;33;150
241;1;low quality;Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis;48;Battafarano, Daniel F.;San Antonio Uniformed Services Health Education Consortium, Fort Sam ;Houston;;United States;48;1104;15;109
241;2;low quality;Psoriatic Skin Lesions Induced by Tumor Necrosis Factor Antagonist Therapy: Clinical Features and Possible Immunopathogenesis;110;Collamer, Angelique N.;Uniformed Services University of the Health Sciences, San Antonio Military Medical Center;Bethesda;;United States;5;301;3;8
245;1;moderate quality;Efficacy and safety of treatments for childhood psoriasis: A systematic literature review ;135;De Jager, Michelle E A;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;16;254;10;27
245;2;moderate quality;Efficacy and safety of treatments for childhood psoriasis: A systematic literature review ;136;De Jong, Elke M G J;Departments of Dermatology;Nijmegen;;Netherlands;200;3368;30;150
245;3;moderate quality;Efficacy and safety of treatments for childhood psoriasis: A systematic literature review ;539;Seyger, Marieke M B;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;121;1192;19;150
245;4;moderate quality;Efficacy and safety of treatments for childhood psoriasis: A systematic literature review ;622;Van de Kerkhof, Peter C. M;Radboud University Medical Center, Department of Dermatology;Nijmegen;;Netherlands;658;13933;52;150
246;1;low quality;Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal;238;Heenen, Michel;Hospital Erasme, Service of Dermatology;Brussels;;Belgium;169;1852;25;150
246;2;low quality;Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal;556;Simonart, Thierry;Dermatology (Private Practice) ;Brussels;;Belgium;133;2351;25;150
246;3;low quality;Epidermal kinetic alterations required to generate the psoriatic phenotype: a reappraisal;313;Lejeune, Olivier;University of Dundee, Division of Mathematics;Dundee;;United Kingdom;21;873;13;24
249;1;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
249;2;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
249;3;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;37;Bagot, Martine;Universite Paris, Laboratoire Immunologie Dermatologie & Oncologie;Paris;;France;474;9399;51;150
249;4;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;64;Bronsard, Valérie;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;7;331;5;21
249;5;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
249;6;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
249;7;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
249;8;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
249;9;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
249;10;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
249;11;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;481;Prey, Sorilla;Hopital des Enfants, Service de Dermatologie Pediatrique et Centre de Reference des Maladies Rares de la Peau;Toulouse;;France;35;828;14;150
249;12;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;485;Puzenat, Ève;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;57;781;15;150
249;13;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;499;Richard-Lallemand, Marie Aleth;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;16;426;8;50
249;14;low quality;What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature;215;Gourraud, Pierre Antoine F D;UCSF Multiple Sclerosis Center;;;United States;90;2381 ;27;150
250;1;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
250;2;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
250;3;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;37;Bagot, Martine;Universite Paris, Laboratoire Immunologie Dermatologie & Oncologie;Paris;;France;474;9399;51;150
250;4;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;64;Bronsard, Valérie;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;7;331;5;21
250;5;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
250;6;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
250;7;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
250;8;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
250;9;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
250;10;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
250;11;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;481;Prey, Sorilla;Hopital des Enfants, Service de Dermatologie Pediatrique et Centre de Reference des Maladies Rares de la Peau;Toulouse;;France;35;828;14;150
250;12;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;485;Puzenat, Ève;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;57;781;15;150
250;13;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;499;Richard-Lallemand, Marie Aleth;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;16;426;8;50
250;14;low quality;What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature;215;Gourraud, Pierre Antoine F D;UCSF Multiple Sclerosis Center;;;United States;90;2381 ;27;150
252;1;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
252;2;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
252;3;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;37;Bagot, Martine;Universite Paris, Laboratoire Immunologie Dermatologie & Oncologie;Paris;;France;474;9399;51;150
252;4;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;64;Bronsard, Valérie;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;7;331;5;21
252;5;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
252;6;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
252;7;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
252;8;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
252;9;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
252;10;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
252;11;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;481;Prey, Sorilla;Hopital des Enfants, Service de Dermatologie Pediatrique et Centre de Reference des Maladies Rares de la Peau;Toulouse;;France;35;828;14;150
252;12;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;485;Puzenat, Ève;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;57;781;15;150
252;13;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;499;Richard-Lallemand, Marie Aleth;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;16;426;8;50
252;14;low quality;Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies;215;Gourraud, Pierre Antoine F D;UCSF Multiple Sclerosis Center;;;United States;90;2381 ;27;150
253;1;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;311;Lecluse, Lidian L A;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;17;382;10;60
253;2;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;436;Nijsten, Tamar E C;Erasmus University Medical Center, Department of Dermatology;Rotterdam;;Netherlands;247;5706;37;150
253;3;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;479;Poulsen, M. L N F;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;7;70;1;5
253;4;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;572;Spuls, Phyllis Ira;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;104;3086;27;150
253;5;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;576;Stern, Robert S;Harvard Medical School, Department of Dermatology, ;Boston;;United States;308;16968;61;150
253;6;low quality;How Good Are Clinical Severity and Outcome Measures for Psoriasis?: Quantitative Evaluation in a Systematic Review;56;Bos, Jan Dositheus;Academic Medical Centre, University of Amsterdam, Netherlands Institute for Pigment Disorders/Department of Dermatology;Amsterdam;;Netherlands;370;17238;69;150
254;1;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;20;Aractingi, Sélim;Hopital Cochin AP-HP, Department of Dermatology ;Paris;;France;271;4582;39;150
254;2;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;29;Aubin, François J.;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;340;5146;39;150
254;3;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;37;Bagot, Martine;Universite Paris, Laboratoire Immunologie Dermatologie & Oncologie;Paris;;France;474;9399;51;150
254;4;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;64;Bronsard, Valérie;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;7;331;5;21
254;5;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;122;Cribier, Bernard J;CHU Strasbourg, Department of Dermatology;Strasbourg;;France;390;6405;42;150
254;6;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;273;Joly, Pascal;CHU Hopitaux de Rouen, Department of Dermatology;Rouen;;France;402;8200;48;150
254;7;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;274;Jullien, Denis;Hopital Edouard Herriot, Department of Dermatology;Lyon;;France;144;3683;36;150
254;8;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;310;Le Maître, Michel;Dermatologist;Caen;;France;106;894;18;150
254;9;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;446;Ortonne, Jean Paul;Hopital l'Archet, Department of Dermatology;Nice;;France;180;4457;36;150
254;10;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;464;Paul, Carle F;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5275 ;39;150
254;11;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;481;Prey, Sorilla;Hopital des Enfants, Service de Dermatologie Pediatrique et Centre de Reference des Maladies Rares de la Peau;Toulouse;;France;35;828;14;150
254;12;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;485;Puzenat, Ève;Centre Hospitalier Universitaire de Besancon, Department of Dermatology;Besancon;;France;57;781;15;150
254;13;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;499;Richard-Lallemand, Marie Aleth;Universite Paul Sabatier Toulouse III, Department of Dermatology;Toulouse;;France;16;426;8;50
254;14;moderate quality;Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: A systematic review of the literature;215;Gourraud, Pierre Antoine F D;UCSF Multiple Sclerosis Center;San Francisco;;United States;90;2381 ;27;150
260;1;low quality;Topical clobetasol propionate in the treatment of psoriasis: A review of newer formulations;175;Feldman, Steven R;Wake Forest Baptist Health;Winston Salem;;United States;812;16583;59;150
260;2;low quality;Topical clobetasol propionate in the treatment of psoriasis: A review of newer formulations;700;Yentzer, Brad A.;Corvallis Clinic;;;United States;66;945;17;102
261;1;low quality;Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literature;200;Gelfand, Joel M;University of Pennsylvania, Center for Clinical Epidemiology and Biostatistics;Philadelphia;;United States;160;8233;43;150
261;2;low quality;Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literature;562;Smith, Nana;University of Rochester, Department of Dermatology;Rochester;;United States;7;423;5;19
261;3;low quality;Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literature;592;Tausk, Francisco A;University of Rochester School of Medicine and Dentistry, Department of Psychiatry;Rochester;;United States;46;772;17;65
261;4;low quality;Complementary and alternative medicine for psoriasis: A qualitative review of the clinical trial literature;655;Weymann, Alex;University of Rochester, School of Medicine;Rochester;;United States;1;23;1;3
262;1;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;18;Anis, Aslam Hayat;St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences;Vancouver;;Canada;200;6691;45;150
262;2;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;44;Bansback, Nick J.;Arthritis Research Canada;Richmond;;Canada;118;2933;26;150
262;3;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;559;Sizto, Sonia;St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences;Vancouver;;Canada;5;189;5;13
262;4;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;580;Sun, Huiying;St. Paul's Hospital, Centre for Health Evaluation and Outcome Sciences;Vancouver;;Canada;34;558;13;65
262;5;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;175;Feldman, Steven R.;Wake Forest Baptist Health;Winston Salem;;United States;812;16636;59;150
262;6;moderate quality;Efficacy of systemic treatments for moderate to severe plaque psoriasis: Systematic review and meta-analysis ;658;Willian, Mary Kaye;University of Kentucky, Department of Pharmaceutical Sciences;Lexington;;United States;39;1398;18;92
266;1;moderate quality;Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: A systematicreview;464;Paul, Carle F.;Universite Paul Sabatier Toulouse III, Department of Maxillofacial Surgery;Toulouse;;France;238;5286;39;150
266;2;moderate quality;Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: A systematicreview;481;Prey, Sorilla;Hopital des Enfants, Service de Dermatologie Pediatrique et Centre de Reference des Maladies Rares de la Peau;Toulouse;;France;35;834;14;150
267;1;moderate quality;Psoriasis (chronic plaque);426;Naldi, Luigi;Ospedale Papa Giovanni XXIII, Centro Studi GISED;Bergamo;;Italy;307;17925;49;150
267;2;moderate quality;Psoriasis (chronic plaque);518;Rzany, Berthold J.;RZANY and HUND;Berlin;;Germany;236;6391;38;150
268;1;moderate quality;Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis ofrandomized controlled trials;288;Kirch, Wilhelm P.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;655;7566;43;150
268;2;moderate quality;Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis ofrandomized controlled trials;406;Meurer, Michael;Rheinisch-Westfalische Technische Hochschule Aachen, Institute of Navigation;Aachen;;Germany;431;6371;47;150
268;3;moderate quality;Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis ofrandomized controlled trials;664;Wozel, Gottfried G.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus, Department of Dermatology;Dresden;;Germany;133;1727 ;21;150
268;4;moderate quality;Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis ofrandomized controlled trials;727;Zhang, Zhengguang;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;4;148;2;8
268;5;moderate quality;Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: Meta-analysis ofrandomized controlled trials;531;Schmitt, Jochen M.;Dresden University Faculty of Medicine and University Hospital Carl Gustav Carus;Dresden;;Germany;167;3323;33;150
269;1;moderate quality;Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials;63;Brimhall, Angela K.;University Hospitals Case Medical Center, Department of Dermatology;Cleveland;;United States;5;254;4;13
269;2;moderate quality;Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials;258;Jacobe, Heidi T.;University of Texas System, Southwestern Medical Center;Austin;;United States;46;1028;17;134
269;3;moderate quality;Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials;287;King, L. N.;UC Davis;Davis;;United States;1;97;1;4
269;4;moderate quality;Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials;342;Licciardone, John C.;University of North Texas, Department of Family Medicine;Denton;;United States;97;1124;18;100
269;5;moderate quality;Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials;405;Menter, Alan M.;Baylor University Medical Center at Dallas, Department of Dermatology;Dallas;;United States;278;15321;60;150
270;1;low quality;Measures used in specifying psoriasis lesion(s), global disease and quality of life: A systematic review;43;Balkrishnan, Rajesh R.;University Michigan Ann Arbor, College of Pharmacy;Ann Arbor;;United States;283;6278;41;150
270;2;low quality;Measures used in specifying psoriasis lesion(s), global disease and quality of life: A systematic review;53;Bhosle, Monali J;MS Consulting Group;Falls Church;yes;United States;37;523;13;69
270;3;low quality;Measures used in specifying psoriasis lesion(s), global disease and quality of life: A systematic review;175;Feldman, Steven R.;Wake Forest Baptist Health;Winston Salem;;United States;812;16583;59;150
270;4;low quality;Measures used in specifying psoriasis lesion(s), global disease and quality of life: A systematic review;198;Garduno, Javier I.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;3;92;3;5
273;1;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;59;Bravo Vergel, Yolanda Bravo;University of York, Centre for Health Economics;York;;United Kingdom;15;399;11;38
273;2;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;87;Chalmers, Robert James Guille;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;121;3189;28;150
273;3;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;237;Hawkins, Neil Stephen;ICON Clinical Research (UK) Ltd., ;Abingdon;yes;United Kingdom;58;1898;20;150
273;4;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;275;Kainth, Anita;University of York, Centre for Reviews and Dissemination;York;;United Kingdom;6;293;5;32
273;5;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;284;Khadjesari, Zarnie C S;King's College London, Institute of Psychiatry;London;;United Kingdom;23;568;13;45
273;6;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;343;Light, Kate;University of York, Centre for Reviews and Dissemination;York;;United Kingdom;26;387;10;81
273;7;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;389;Mason, Anne R.;University of York, Centre for Health Economics;York;;United Kingdom;65;1426;17;114
273;8;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;414;Misso, Kate V.;Kleijnen Systematic Reviews Ltd;York;yes;United Kingdom;31;1036;15;104
273;9;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;502;Riemsma, Robert Paul;Kleijnen Systematic Reviews Ltd;York;yes;United Kingdom;82;2306;28;149
273;10;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;534;Sculpher, Mark John S;University of York, Centre for Health Economics;York;;United Kingdom;260;10908;54;150
273;11;high quality;Etanercept and efalizumab for the treatment of psoriasis: a systematic review.;663;Woolacott, Nerys F.;University of York, Centre for Reviews and Dissemination;York;;United Kingdom;87;1732;25;150
276;1;moderate quality;The role of antimalarials in the exacerbation of psoriasis: A systematic review;243;Herman, Sari M.;McMaster University, Department of Medicine;Hamilton;;Canada;2;47;2;4
276;2;moderate quality;The role of antimalarials in the exacerbation of psoriasis: A systematic review;246;Holbrook, Anne Marie;McMaster University, Department of Medicine;Hamilton;;Canada;119;9562;34;150
276;3;moderate quality;The role of antimalarials in the exacerbation of psoriasis: A systematic review;507;Rosenthal, Donald I.;McMaster University, Department of Medicine;Hamilton;;Canada;42;968;19;109
276;4;moderate quality;The role of antimalarials in the exacerbation of psoriasis: A systematic review;554;Shin, Michael H.;McMaster University, Department of Medicine;Hamilton;;Canada;1;11;1;3
280;1;high quality;Interventions for chronic palmoplantar pustulosis.;88;Chalmers, Robert James Guille;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;121;3189;28;150
280;2;high quality;Interventions for chronic palmoplantar pustulosis.;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25834;85;150
280;3;high quality;Interventions for chronic palmoplantar pustulosis.;247;Hollis, Sally;AstraZeneca;London;;United Kingdom;108;5126;36;150
280;4;high quality;Interventions for chronic palmoplantar pustulosis.;314;Leonardi-Bee, Jo A.;University of Nottingham, Division of Epidemiology and Public Health;Nottingham;;United Kingdom;111;4103;32;150
280;5;high quality;Interventions for chronic palmoplantar pustulosis.;385;Marsland, Alexander M.;University of Manchester, Manchester Academic Health Science Center;Manchester;;United Kingdom;14;220;6;44
283;1;low quality;A systematic review of adverse effects associated with topical treatments for psoriasis;66;Bruner, Christine R.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;2;46;2;3
283;2;low quality;A systematic review of adverse effects associated with topical treatments for psoriasis;175;Feldman, Steven R.;Wake Forest Baptist Health;Winston Salem;;United States;812;16583;59;150
283;3;low quality;A systematic review of adverse effects associated with topical treatments for psoriasis;181;Fleischer, Alan B.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;311;9157;46;150
283;4;low quality;A systematic review of adverse effects associated with topical treatments for psoriasis;632;Ventrapragada, Madhuri;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;3;129;3;6
284;1;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;56;Bos, Jan Dositheus;Academic Medical Centre, University of Amsterdam, Netherlands Institute for Pigment Disorders/Department of Dermatology;Amsterdam;;Netherlands;373;17274;69;150
284;2;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;138;De Rie, Menno A.;Dutch Skin Foundation;Utrecht;;Netherlands;132;3852;32;150
284;3;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;245;Heydendael, Vera M R;Kennemer Hospital;Haarlem;;Netherlands;15;582;9;37
284;4;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;444;Opmeer, Brent C.;Academic Medical Centre, University of Amsterdam, Clinical Research Unit;Amsterdam;;Netherlands;158;2504;24;150
284;5;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;572;Spuls, Phyllis Ira;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;105;3101;27;150
284;6;moderate quality;Cyclosporin trough levels: Is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data ontrough levels;598;Ten Berge, Ineke J M;Academic Medical Centre, University of Amsterdam, Department of Internal Medicine;Amsterdam;;Netherlands;208;5850;43;150
285;1;moderate quality;Topical preparations for the treatment of psoriasis: A systematic review;115;Cork, Michael J.;Sheffield Children's Hospital, The Pediatric Dermatology Clinic;Sheffield;;United Kingdom;99;4765;33;150
285;2;moderate quality;Topical preparations for the treatment of psoriasis: A systematic review;389;Mason, Anne R.;University of York, Centre for Health Economics;York;;United Kingdom;66;1433;17;116
285;3;moderate quality;Topical preparations for the treatment of psoriasis: A systematic review;390;Mason, J. M.;Warwick Medical School;Coventry;;United Kingdom;205;8030;41;150
286;1;low quality;A systematic review of treatments for guttate psoriasis;89;Chalmers, Robert James Guille;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;121;3189;28;150
286;2;low quality;A systematic review of treatments for guttate psoriasis;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25840;85;150
286;3;low quality;A systematic review of treatments for guttate psoriasis;440;O'Sullivan, Teresa M;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;7;590;6;6
286;4;low quality;A systematic review of treatments for guttate psoriasis;449;Owen, Caroline M.;Burnley General Hospital, Department of Dermatology;Burnley;;United Kingdom;25;302;10;54
287;1;low quality;A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis;89;Chalmers, Robert James Guille;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;121;3189;28;150
287;2;low quality;A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25840;85;150
287;3;low quality;A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis;440;O'Sullivan, Teresa M;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;7;590;6;6
287;4;low quality;A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis;449;Owen, Caroline M.;Burnley General Hospital, Department of Dermatology;Burnley;;United Kingdom;25;302;10;54
288;1;moderate quality;Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability ;27;Ashcroft, Darren M.;Manchester Academic Health Sciences Centre, NIHR Greater Manchester Patient Safety Translational Research Centre;Manchester;;United Kingdom;163;3322;29;150
288;2;moderate quality;Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability ;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25879;85;150
288;3;moderate quality;Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability ;474;Po, A. L W;Keele University, Department of Medicines Management;Keele;;United Kingdom;2;37;2;3
288;4;moderate quality;Combination regimens of topical calcipotriene in chronic plaque psoriasis: Systematic review of efficacy and tolerability ;657;Williams, Hywel C G;University of Nottingham, Centre of Evidence Based Dermatology,;Nottingham;;United Kingdom;413;26392;67;150
289;1;moderate quality;A systematic review of treatments for severe psoriasis;89;Chalmers, Robert James Guille;University of Manchester, Dermatology Centre;Manchester;;United Kingdom;121;3195;28;150
289;2;moderate quality;A systematic review of treatments for severe psoriasis;108;Clark, Christine M.;Christine Clark Ltd;Lancashire;;United Kingdom;93;454;10;81
289;3;moderate quality;A systematic review of treatments for severe psoriasis;216;Griffiths, Christopher E. M;NHS Foundation Trust;Leeds;;United Kingdom;611;25879;85;150
289;4;moderate quality;A systematic review of treatments for severe psoriasis;320;Li-Wan-Po, Alain;Centre for Evidence-Based Pharmacotherapy;Nottingham;;United Kingdom;105;2686;24;150
289;5;moderate quality;A systematic review of treatments for severe psoriasis;657;Williams, Hywel C G;University of Nottingham, Centre of Evidence Based Dermatology,;Nottingham;;United Kingdom;413;26392;67;150
290;1;moderate quality;Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis;27;Ashcroft, Darren M;Manchester Academic Health Sciences Centre, NIHR Greater Manchester Patient Safety Translational Research Centre;Manchester;;United Kingdom;163;3322;29;150
290;2;moderate quality;Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis;216;Griffiths, Christopher E. M.;NHS Foundation Trust;Leeds;;United Kingdom;611;25879;85;150
290;3;moderate quality;Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis;320;Li-Wan-Po, Alain;Centre for Evidence-Based Pharmacotherapy;Nottingham;;United Kingdom;105;2686;24;150
290;4;moderate quality;Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis;657;Williams, Hywel C G;University of Nottingham, Centre of Evidence Based Dermatology,;Nottingham;;United Kingdom;413;26392;67;150
291;1;moderate quality;Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature;460;Pasker-De Jong, Pieternel C M;Meander Medical Center, Department of Research;Amersfoort;;Netherlands;40;794;14;150
291;2;moderate quality;Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature;624;Van Der Valk, Pieter Gm M;Bethesda Hospital, Department of Dermatology;Hoogeveen;;Netherlands;140;2613;30;150
291;3;moderate quality;Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature;626;Van Der Wilt, Gert Jan An;Radboud University Medical Center, Department of Health Evidence;Nijmegen;;Netherlands;135;3126;28;150
291;4;moderate quality;Treatment with UV-B for psoriasis and nonmelanoma skin cancer: A systematic review of the literature;656;Wielink, Gina;Radboud University Nijmegen, Dept. of Med. Technology Assessment;Nijmegen;;Netherlands;8;155;5;29
294;1;moderate quality;A systematic review of five systemic treatments for severe psoriasis;56;Bos, Jan Dositheus;Academic Medical Centre, University of Amsterdam, Netherlands Institute for Pigment Disorders/Department of Dermatology;Amsterdam;;Netherlands;373;17274;69;150
294;2;moderate quality;A systematic review of five systemic treatments for severe psoriasis;57;Bossuyt, Patrick MM M M;Academic Medical Centre, University of Amsterdam, Clinical Research Unit;Amsterdam;;Netherlands;765;39743;97;150
294;3;moderate quality;A systematic review of five systemic treatments for severe psoriasis;572;Spuls, Phyllis Ira;Academic Medical Centre, University of Amsterdam, Department of Dermatology;Amsterdam;;Netherlands;105;3101;27;150
294;4;moderate quality;A systematic review of five systemic treatments for severe psoriasis;660;Witkamp, Leonard;KSYOS TeleMedical Centre;Amstelveen;yes;Netherlands;29;363;9;62
298;1;moderate quality;Association between MTHFR 677C/T polymorphism and psoriasis risk: A meta-analysis ;101;Chen, Y. J;Hubei Polytechnic University, Department of Dermatology;Hubei;;China;2;1;1;6
298;2;moderate quality;Association between MTHFR 677C/T polymorphism and psoriasis risk: A meta-analysis ;435;Nie, G;Hubei Polytechnic University, Department of Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention;Hubei;;China;4;3;1;12
298;3;moderate quality;Association between MTHFR 677C/T polymorphism and psoriasis risk: A meta-analysis ;486;Qi, J. H;Hubei Polytechnic University, Department of Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention;Hubei;;China;4;3;1;12
298;4;moderate quality;Association between MTHFR 677C/T polymorphism and psoriasis risk: A meta-analysis ;486;Qi, J. H;Hubei Polytechnic University, Department of Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention;Hubei;;China;2;2;1;5
298;5;moderate quality;Association between MTHFR 677C/T polymorphism and psoriasis risk: A meta-analysis ;552;Shi, N;Hubei Polytechnic University, Department of Dermatology;Hubei;;China;2;1;1;6
300;1;moderate quality;Associations between interleukin-23R and interleukin-12B polymorphisms and psoriasis susceptibility: A meta-analysis  ;312;Lee, Youngho;Korea University Medical Center, Division of Rheumatology;Seoul;;South Korea;277;5009 ;33;150
300;2;moderate quality;Associations between interleukin-23R and interleukin-12B polymorphisms and psoriasis susceptibility: A meta-analysis  ;568;Song, Gwangyu;Korea University Medical Center, Department of Internal Medicine;Seoul;;South Korea;245;3467;29;150
301;1;low quality;Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis;565;Sobolev, Vladimir V.;Weizmann Institute of Science Israel, Department of Plant Sciences;Rehovot;;Israel;44;1749;19;110
301;2;low quality;Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis;67;Bruskin, Sergey A.;Russian Academy of Sciences;Moscow;;Russian Federation;33;100 ;5;78
301;3;low quality;Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis;407;Mezentsev, Alexandre;Russian Academy of Sciences, Vavilov Institute of General Genetics;Moscow;;Russian Federation;20;517;11;62
301;4;low quality;Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis;473;Piruzian, Eleonora S.;Russian Academy of Sciences, Vavilov Institute of General Genetics;Moscow;;Russian Federation;106;389;9;139
301;5;low quality;Pharmacological control of receptor of ddvanced glycation end-products and its biological effects in psoriasis;566;Soboleva, Anna G;Russian Academy of Sciences, Vavilov Institute of General Genetics;Moscow;;Russian Federation;14;25;3;24
303;1;low quality;Comparative efficacy of biologics in psoriasis: A review;175;Feldman, Steven R.;Wake Forest Baptist Health;Winston Salem;;United States;812;16583;59;150
303;2;low quality;Comparative efficacy of biologics in psoriasis: A review;285;Kim, Iris H.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;1;31;1;4
303;3;low quality;Comparative efficacy of biologics in psoriasis: A review;439;O'Neill, Jenna L.;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;33;308;11;73
303;4;low quality;Comparative efficacy of biologics in psoriasis: A review;654;West, Cameron Edward;Wake Forest University School of Medicine, Department of Dermatology;Winston Salem;;United States;37;381;12;47
303;5;low quality;Comparative efficacy of biologics in psoriasis: A review;298;Kwatra, Shawn Gaurav;Johns Hopkins University, Department of Dermatology;Baltimore;;United States;58;214;8;88
304;1;moderate quality;Alcohol consumption and psoriatic risk: A meta-analysis of case-control studies;170;Fan, Yiming;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;61;241 ;10;126
304;2;moderate quality;Alcohol consumption and psoriatic risk: A meta-analysis of case-control studies;735;Zhu, Chengyao;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;18;198;7;106
304;3;moderate quality;Alcohol consumption and psoriatic risk: A meta-analysis of case-control studies;736;Zhu, Kunju;Guangdong Medical College, Department of Dermatology;Zhanjiang;;China;36;1022;12;150
